10-Q

UNITED STATES SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

þ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2008

or

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                          to                         

Commission File number 1-8923

HEALTH CARE REIT, INC.

(Exact name of registrant as specified in its charter)

Delaware	34-1096634
(State or other jurisdiction of	(I.R.S. Employer
incorporation or organization)	Identification No.)
One SeaGate, Suite 1500, Toledo, Ohio	43604
(Address of principal executive office)	(Zip Code)
(419) 247-2800
(Registrant’s telephone number, including area code)

(Former name, former address and former fiscal year, if changed since last report)

     Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to the filing requirements for at least the past 90 days.

Yes þ No o

     Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer þ Accelerated filer o Non-accelerated filer o (Do not check if a smaller reporting company) Smaller reporting company o

     Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes o No þ

     As of July 31, 2008, the registrant had 94,909,084 shares of common stock outstanding.

TABLE OF CONTENTS

	Page
PART I. FINANCIAL INFORMATION
Item 1. Financial Statements (Unaudited)
Consolidated Balance Sheets — June 30, 2008 and December 31, 2007	3
Consolidated Statements of Income — Three months and six ended June 30, 2008 and 2007	4
Consolidated Statements of Stockholders’ Equity — Three months and six ended June 30, 2008 and 2007	5
Consolidated Statements of Cash Flows — Six months ended June 30, 2008 and 2007	6
Notes to Unaudited Consolidated Financial Statements	7
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations	20
Item 3. Quantitative and Qualitative Disclosures About Market Risk	42
Item 4. Controls and Procedures	43
PART II. OTHER INFORMATION
Item 1A. Risk Factors	43
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	43
Item 4. Submission of Matters to a Vote of Security Holders	43
Item 6. Exhibits	44
Signatures	44
EX-10.1
EX-10.2
EX-10.3
EX-10.4
EX-31.1
EX-31.2
EX-32.1
EX-32.2

2

PART I. FINANCIAL INFORMATION

Item 1. Financial Statements

CONSOLIDATED BALANCE SHEETS
HEALTH CARE REIT, INC. AND SUBSIDIARIES

	June 30,			December 31,
	2008			2007
	(Unaudited)			(Note)
	(In thousands)
Assets
Real estate investments:
Real property owned:
Land and land improvements	$	480,481		$	447,029
Buildings and improvements		4,486,489			4,224,955
Acquired lease intangibles		134,636			131,312
Real property held for sale, net of accumulated depreciation		42,153			0
Construction in progress		369,833			313,709
Gross real property owned		5,513,592			5,117,005
Less accumulated depreciation and amortization		(535,381	)		(478,373	)
Net real property owned		4,978,211			4,638,632
Real estate loans receivable:
Real estate loans receivable		497,133			381,394
Less allowance for losses on loans receivable		(7,406	)		(7,406	)
Net real estate loans receivable		489,727			373,988
Net real estate investments		5,467,938			5,012,620
Other assets:
Equity investments		1,287			1,408
Deferred loan expenses		27,067			30,499
Cash and cash equivalents		25,078			30,269
Restricted cash		149,694			17,575
Receivables and other assets		133,950			121,485
Total other assets		337,076			201,236
Total assets	$	5,805,014		$	5,213,856
Liabilities and stockholders’ equity
Liabilities:
Borrowings under unsecured lines of credit arrangements	$	744,000		$	307,000
Senior unsecured notes		1,847,555			1,890,192
Secured debt		465,399			507,476
Accrued expenses and other liabilities		107,267			95,145
Total liabilities		3,164,221			2,799,813
Minority interests		7,669			9,687
Stockholders’ equity:
Preferred stock, $1.00 par value:		305,681			330,243
Authorized - 50,000,000 shares
Issued and outstanding - 12,048,839 shares at June 30, 2008 and 12,879,189 shares at December 31, 2007
Common stock, $1.00 par value:		89,981			85,412
Authorized - 225,000,000 shares
Issued - 90,261,733 shares at June 30, 2008 and 85,600,333 shares at December 31, 2007
Outstanding - 90,130,579 shares at June 30, 2008 and 85,496,164 shares at December 31, 2007
Capital in excess of par value		2,551,620			2,370,037
Treasury stock		(5,110	)		(3,952	)
Cumulative net income		1,273,251			1,074,255
Cumulative dividends		(1,577,301	)		(1,446,959	)
Accumulated other comprehensive income		(8,546	)		(7,381	)
Other equity		3,548			2,701
Total stockholders’ equity		2,633,124			2,404,356
Total liabilities and stockholders’ equity	$	5,805,014		$	5,213,856

NOTE: The consolidated balance sheet at December 31, 2007 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by U.S. generally accepted accounting principles for complete financial statements.

See notes to unaudited consolidated financial statements

3

CONSOLIDATED STATEMENTS OF INCOME (UNAUDITED)
HEALTH CARE REIT, INC. AND SUBSIDIARIES

	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2008			2007			2008			2007
	(In thousands, except per share data)
Revenues:
Rental income	$	124,828		$	105,023		$	244,868		$	203,641
Interest income		9,175			6,576			18,267			11,725
Other income		1,885			1,144			3,601			2,737
Total revenues		135,888			112,743			266,736			218,103
Expenses:
Interest expense		31,948			31,692			65,043			61,601
Property operating expenses		11,375			8,657			22,742			15,825
Depreciation and amortization		38,475			33,278			76,874			64,805
General and administrative		10,575			9,957			22,904			19,738
Loan expense		1,753			1,236			3,524			2,503
Loss (gain) on extinguishment of debt		0			0			(1,326	)		0
Total expenses		94,126			84,820			189,761			164,472
Income from continuing operations before income taxes and minority interests		41,762			27,923			76,975			53,631
Income tax (expense) benefit		(44	)		69			(1,323	)		58
Income from continuing operations before minority interests		41,718			27,992			75,652			53,689
Minority interests, net of tax		(65	)		(161	)		(127	)		(286	)
Income from continuing operations		41,653			27,831			75,525			53,403
Discontinued operations:
Net gain (loss) on sales of properties		118,168			1,033			118,194			2,010
Income (loss) from discontinued operations, net		2,576			3,073			5,277			6,197
Discontinued operations, net		120,744			4,106			123,471			8,207
Net income		162,397			31,937			198,996			61,610
Preferred stock dividends		5,784			6,317			11,931			12,634
Net income available to common stockholders	$	156,613		$	25,620		$	187,065		$	48,976
Average number of common shares outstanding:
Basic		89,294			79,060			87,698			76,159
Diluted		89,853			79,546			88,223			76,714
Earnings per share:
Basic:
Income from continuing operations available to common stockholders	$	0.40		$	0.27		$	0.73		$	0.54
Discontinued operations, net		1.35			0.05			1.41			0.11
Net income available to common stockholders*	$	1.75		$	0.32		$	2.13		$	0.64
Diluted:
Income from continuing operations available to common stockholders	$	0.40		$	0.27		$	0.72		$	0.53
Discontinued operations, net		1.34			0.05			1.40			0.11
Net income available to common stockholders*	$	1.74		$	0.32		$	2.12		$	0.64
Dividends declared and paid per common share	$	0.68		$	0.66		$	1.34		$	0.9591

* Amounts may not sum due to rounding

See notes to unaudited consolidated financial statements

4

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (UNAUDITED)
HEALTH CARE REIT, INC. AND SUBSIDIARIES

	Six Months Ended June 30, 2008
																Accumulated
						Capital in										Other
	Preferred			Common		Excess of		Treasury			Cumulative		Cumulative			Comprehensive			Other
	Stock			Stock		Par Value		Stock			Net Income		Dividends			Income			Equity			Total
	(In thousands)
Balances at beginning of period	$	330,243		$	85,412	$	2,370,037	$	(3,952	)	$	1,074,255	$	(1,446,959	)	$	(7,381	)	$	2,701		$	2,404,356
Comprehensive income:
Net income												198,996											198,996
Other comprehensive income:
Unrealized gain (loss) on equity investments																	(589	)					(589	)
Cash flow hedge activity																	(576	)					(576	)
Total comprehensive income																							197,831
Amounts related to issuance of common stock from dividend reinvestment and stock incentive plans, net of forfeitures					975		42,060		(1,158	)										(87	)		41,790
Net proceeds from sale of common stock					3,000		115,555																118,555
Conversion of preferred stock		(24,562	)		594		23,968																0
Option compensation expense																				934			934
Cash dividends paid:
Common stock-$1.34 per share														(118,411	)								(118,411	)
Preferred stock, Series D-$0.9844 per share														(3,938	)								(3,938	)
Preferred stock, Series E-$0.75 per share														(56	)								(56	)
Preferred stock, Series F-$0.9532 per share														(6,672	)								(6,672	)
Preferred stock, Series G-$0.9376 per share														(1,265	)								(1,265	)
Balances at end of period	$	305,681		$	89,981	$	2,551,620	$	(5,110	)	$	1,273,251	$	(1,577,301	)	$	(8,546	)	$	3,548		$	2,633,124

	Six Months Ended June 30, 2007
															Accumulated
					Capital in										Other
	Preferred		Common		Excess of		Treasury			Cumulative		Cumulative			Comprehensive			Other
	Stock		Stock		Par Value		Stock			Net Income		Dividends			Income			Equity			Total
	(In thousands)
Balances at beginning of period	$	338,993	$	73,152	$	1,873,811	$	(2,866	)	$	932,853	$	(1,238,860	)	$	(135	)	$	1,845		$	1,978,793
Comprehensive income:
Net income											61,610											61,610
Other comprehensive income																						0
Total comprehensive income																						61,610
Amounts related to issuance of common stock from dividend reinvestment and stock incentive plans, net of forfeitures				1,275		48,726		(1,075	)										(114	)		48,812
Proceeds from issuance of common shares				6,325		259,293																265,618
Option compensation expense																			729			729
Cash dividends paid:
Common stock-$0.9591 per share													(75,524	)								(75,524	)
Preferred stock, Series D-$0.9844 per share													(3,937	)								(3,937	)
Preferred stock, Series E-$0.75 per share													(56	)								(56	)
Preferred stock, Series F-$0.9532 per share													(6,672	)								(6,672	)
Preferred stock, Series G-$0.9376 per share													(1,969	)								(1,969	)
Balances at end of period	$	338,993	$	80,752	$	2,181,830	$	(3,941	)	$	994,463	$	(1,327,018	)	$	(135	)	$	2,460		$	2,267,404

See notes to unaudited consolidated financial statements

5

CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
HEALTH CARE REIT, INC. AND SUBSIDIARIES

	Six Months Ended
	June 30,
	2008			2007
	(In thousands)
Operating activities
Net income	$	198,996		$	61,610
Adjustments to reconcile net income to net cash provided from (used in) operating activities:
Depreciation and amortization		79,203			69,408
Other amortization expenses		3,483			2,315
Capitalized interest		(10,230	)		(4,896	)
Stock-based compensation expense		5,254			4,453
Minority interests share of earnings		127			286
Loss (gain) on extinguishment of debt, net		(1,326	)		0
Rental income less than (in excess of) cash received		528			(3,199	)
Amortization related to above (below) market leases, net		(462	)		(924	)
(Gain) loss on sales of properties		(118,194	)		(2,010	)
Deferred (gain) loss on sales of properties		3,708			0
Increase (decrease) in accrued expenses and other liabilities		6,996			(8,652	)
Decrease (increase) in receivables and other assets		(1,654	)		544
Net cash provided from (used in) operating activities		166,429			118,935
Investing activities
Investment in real property		(533,978	)		(270,123	)
Investment in real estate loans receivable		(67,352	)		(89,959	)
Other investments, net of payments		(9,763	)		(1,389	)
Principal collected on real estate loans receivable		13,401			35,601
Investment in Rendina/Paramount, net of cash assumed		0			(141,963	)
Decrease (increase) in restricted cash		(132,126	)		(7,026	)
Proceeds from sales of real property		183,081			24,183
Other		(5,503	)		(1,673	)
Net cash provided from (used in) investing activities		(552,240	)		(452,349	)
Financing activities
Net increase (decrease) under unsecured lines of credit arrangements		437,000			139,400
Principal payments on senior unsecured notes		(42,330	)		0
Principal payments on secured debt		(40,612	)		(24,300	)
Net proceeds from the issuance of common stock		157,094			309,830
Decrease (increase) in deferred loan expense		(23	)		(882	)
Contributions by minority interests		243			0
Distributions to minority interests		(410	)		(220	)
Cash distributions to stockholders		(130,342	)		(88,158	)
Net cash provided from (used in) financing activities		380,620			335,670
Increase (decrease) in cash and cash equivalents		(5,191	)		2,256
Cash and cash equivalents at beginning of period		30,269			36,216
Cash and cash equivalents at end of period	$	25,078		$	38,472

See notes to unaudited consolidated financial statements

6

HEALTH CARE REIT, INC.

NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS

1. Business

     Health Care REIT, Inc., with headquarters in Toledo, Ohio, is an equity real estate investment trust (“REIT”) that invests in senior housing and health care real estate. Our full service platform also offers property management and development services to our customers. As of June 30, 2008, our broadly diversified portfolio consisted of 635 properties in 38 states. Founded in 1970, we were the first real estate investment trust to invest exclusively in health care facilities. More information is available on the Internet at www.hcreit.com.

2. Accounting Policies and Related Matters

Basis of Presentation

     The accompanying unaudited consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles (“U.S. GAAP”) for interim financial information and with instructions to Quarterly Report on Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of normal recurring accruals) considered necessary for a fair presentation have been included. Operating results for the six months ended June 30, 2008 are not necessarily an indication of the results that may be expected for the year ending December 31, 2008. For further information, refer to the financial statements and footnotes thereto included in our Annual Report on Form 10-K for the year ended December 31, 2007, as updated by our Current Report on Form 8-K filed June 27, 2008.

New Accounting Standards

     In September 2006, the Financial Accounting Standards Board (“FASB”) issued Statement of Financial Accounting Standards No. 157, Fair Value Measurements (“SFAS 157”). SFAS 157 introduces a framework for measuring fair value and expands required disclosure about fair value measurements of assets and liabilities. SFAS 157 for financial assets and liabilities is effective for fiscal years beginning after November 15, 2007, and was adopted as the standard for those assets and liabilities as of January 1, 2008. The impact of adoption was not significant. SFAS 157 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. SFAS 157 also establishes a fair value hierarchy which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The standard describes three levels of inputs that may be used to measure fair value:

Level 1 — Quoted prices in active markets for identical assets or liabilities.

Level 2 — Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities. Interest rate swap agreements are valued using models that assume a hypothetical transaction to sell the asset or transfer the liability in the principal market for the asset or liability based on market data derived from interest rates and yield curves observable at commonly quoted intervals, volatilities, prepayment timing, loss severities, credit risks and default rates.

Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

     The market approach is utilized to measure fair value for our financial assets and liabilities. The market approach uses prices and other relevant information generated by market transactions involving identical or comparable assets or liabilities.

	Fair Value Measurements as of June 30, 2008
	Total			Level 1		Level 2			Level 3
Equity investments (1)	$	818		$	818	$	0		$	0
Interest rate swap agreements (1)		(8,486	)		0		(8,486	)		0
Totals	$	(7,668	)	$	818	$	(8,486	)	$	0

(1) Unrealized gains or losses on equity investments and interest rate swap agreements are recorded in accumulated other comprehensive income (loss) at each measurement date.

7

HEALTH CARE REIT, INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS — Continued

     In December 2007, the FASB issued Statement of Financial Accounting Standards No. 141(R), Business Combinations (“SFAS 141(R)”) and Statement of Financial Accounting Standards No. 160, Noncontrolling Interests in Consolidated Financial Statements, an amendment of ARB No. 51 (“SFAS 160”). SFAS 141(R) will change how business acquisitions are accounted for and will impact financial statements both on the acquisition date and in subsequent periods. SFAS 160 will change the accounting and reporting for minority interests, which will be recharacterized as noncontrolling interests and classified as a component of equity. Early adoption is prohibited for both standards. The provisions of SFAS 141(R) and SFAS 160, effective on January 1, 2009, are to be applied prospectively; however, the disclosure provisions of SFAS 160 are to be applied retrospectively. We are currently assessing the impact of SFAS 141(R) and SFAS 160 on our consolidated financial position and results of operations.

     In March 2008, the FASB issued Statement of Financial Accounting Standards No. 161, Disclosures About Derivative Instruments and Hedging Activities — an amendment of FASB Statement No. 133 (“SFAS 161”). SFAS 161 expands quarterly disclosure requirements in SFAS 133 concerning an entity’s derivative instruments and hedging activities. SFAS 161 is effective for fiscal years beginning after November 15, 2008. We are currently assessing the impact of SFAS 161 on our consolidated financial position and results of operations.

     In May 2008, the FASB issued FASB Staff Position 14-1, (“FSP”) which provides guidance on accounting for debt that may be settled in cash upon conversion. The FSP requires bifurcation of the convertible debt instrument into a debt component and an equity component. The value of the debt component is based upon the estimated fair value of a similar debt instrument without the conversion feature. The difference between the contractual principal on the debt and the value allocated to the debt is recorded as an equity component and represents the conversion feature of the instrument. The excess of the contractual principal amount of the debt over its estimated fair value is amortized to interest expense using the effective interest method over the life of the debt. The equity component remains on the balance sheet until it is derecognized through either the payoff or conversion. The FSP is effective for fiscal years beginning after December 16, 2008, and interim periods within those fiscal years. Earlier application is not permitted. Retroactive application is required for all periods presented in the annual financial statements for instruments that were outstanding during any periods presented in the annual financial statements. We are currently assessing the impact of the FSP on our consolidated financial position and results of operations.

3. Real Property Acquisitions and Development

     The following is a summary of our real property investment activity for the periods presented (in thousands):

	Six Months Ended
	June 30, 2008									June 30, 2007
	Investment			Medical Office						Investment			Medical Office
	Properties			Buildings			Totals			Properties			Buildings			Totals
Real property acquisitions:
Independent living/CCRCs	$	68,300					$	68,300		$	0					$	0
Assisted living facilities		45,490						45,490			9,875						9,875
Skilled nursing facilities		0						0			103,300						103,300
Specialty care facilities		142,300						142,300			11,923						11,923
Medical office buildings		0		$	47,853			47,853			0		$	314,175			314,175
Land parcels		10,000						10,000			6,127						6,127
Total acquisitions		266,090			47,853			313,943			131,225			314,175			445,400
Less: Assumed debt								0						(146,457	)		(146,457	)
Assumed other assets (liabilities), net					(967	)		(967	)					(3,643	)		(3,643	)
Cash disbursed for acquisitions		266,090			46,886			312,976			131,225			164,075			295,300
Construction in progress additions:
Independent living/CCRCs		112,345						112,345			47,125						47,125
Assisted living facilities		50,290						50,290			27,061						27,061
Skilled nursing facilities		8,736						8,736			7,849						7,849
Specialty care facilities		35,726						35,726			27,372						27,372
Medical office buildings		0			13,628			13,628			0			0			0
Total construction in progress additions		207,097			13,628			220,725			109,407			0			109,407
Less: Capitalized interest		(9,794	)		(436	)		(10,230	)		(4,887	)					(4,887	)
Cash disbursed for construction in progress		197,303			13,192			210,495			104,520			0			104,520
Capital improvements to existing properties		7,828			2,679			10,507			10,592			1,674			12,266
Total cash invested in real property	$	471,221		$	62,757		$	533,978		$	246,337		$	165,749		$	412,086

8

HEALTH CARE REIT, INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS — Continued

     The following is a summary of the development projects that were placed into service and began earning rent during the periods presented:

	Six Months Ended
	June 30, 2008						June 30, 2007
	Investment		Medical Office				Investment		Medical Office
	Properties		Buildings		Totals		Properties		Buildings		Totals
Construction in progress conversions:
Development projects:
Independent living/CCRCs	$	91,218			$	91,218	$	22,583			$	22,583
Assisted living facilities		14,516				14,516		42,454				42,454
Skilled nursing facilities						0		7,910				7,910
Medical office buildings			$	0		0			$	0		0
Specialty care facilities		35,151				35,151						0
Total development projects		140,885		0		140,885		72,947		0		72,947
Expansion projects		23,718				23,718		1,274				1,274
Total construction in progress conversions	$	164,603	$	0	$	164,603	$	74,221	$	0	$	74,221

4. Real Estate Intangibles

     The following is a summary of our real estate intangibles as of the dates indicated (dollars in thousands):

	June 30, 2008			December 31, 2007
Assets:
In place lease intangibles	$	82,759		$	81,068
Above market tenant leases		9,853			9,592
Below market ground leases		42,024			40,652
Gross historical cost		134,636			131,312
Accumulated amortization		(26,969	)		(18,289	)
Net book value	$	107,667		$	113,023
Weighted-average amortization period in years		24.4			28.4
Liabilities:
Below market tenant leases	$	25,654		$	25,186
Above market ground leases		3,499			3,499
Gross historical cost		29,153			28,685
Accumulated amortization		(6,810	)		(4,446	)
Net book value	$	22,343		$	24,239
Weighted-average amortization period in years		9.8			10.0

9

HEALTH CARE REIT, INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS — Continued

5. Dispositions, Assets Held for Sale and Discontinued Operations

     At June 30, 2008, we had ten assisted living facilities and one skilled nursing facility that satisfied the requirements of Statement No. 144 for held for sale treatment. We did not recognize any impairment loss on these assets as the fair value less estimated costs to sell exceeded our carrying values. The following is a summary of our real property disposition activity for the periods presented (in thousands):

	Six Months Ended
	June 30, 2008								June 30, 2007
	Investment			Medical Office					Investment		Medical Office
	Properties			Buildings		Totals			Properties		Buildings		Totals
Real property dispositions:
Independent living/CCRCs	$	15,547				$	15,547
Assisted living facilities		105,244					105,244		$	14,796			$	14,796
Skilled nursing facilities		3,672					3,672			4,304				4,304
Medical office buildings		0		$	0		0			0	$	0		0
Land parcels		73					73			3,073				3,073
Total dispositions		124,536			0		124,536			22,173		0		22,173
Less: Gain/(loss) on sales of real property		118,194					118,194			2,010				2,010
Seller financing on sales of real property		(59,649	)				(59,649	)		0				0
Proceeds from real property sales	$	183,081		$	0	$	183,081		$	24,183	$	0	$	24,183

     During the six months ended June 30, 2008, we completed the sale of 19 properties to Emeritus Corporation for $222,656,000, consisting of $172,656,000 in cash proceeds and $50,000,000 of seller financing, and we recognized a gain on sale of $113,505,000. Total funds of $222,656,000 were held in escrow for use in an Internal Revenue Code Section 1031 exchange, of which $88,372,000 was utilized during the six months ended June 30, 2008.

     In accordance with Statement of Financial Accounting Standards No. 144, Accounting for the Impairment or Disposal of Long-Lived Assets, we have reclassified the income and expenses attributable to all properties sold and attributable to properties held for sale at June 30, 2008 to discontinued operations. Expenses include an allocation of interest expense based on property carrying values and our weighted average cost of debt. The following illustrates the reclassification impact of Statement No. 144 as a result of classifying properties as discontinued operations for the periods presented (in thousands):

	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2008		2007		2008		2007
Revenues:
Rental income	$	4,982	$	7,274	$	10,108	$	14,823
Expenses:
Interest expense		1,251		1,932		2,502		4,023
Provision for depreciation		1,155		2,269		2,329		4,603
Income (loss) from discontinued operations, net	$	2,576	$	3,073	$	5,277	$	6,197

10

HEALTH CARE REIT, INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS — Continued

6. Real Estate Loans Receivable

     All real estate loans receivable are in our investment property segment. The following is a summary of our real estate loan activity for the periods presented (in thousands):

	Six Months Ended
	June 30, 2008			June 30, 2007
	Amount			Amount
Advances on real estate loans receivable:
Investments in new loans	$	117,763		$	76,875
Draws on existing loans		9,238			13,084
Total gross investments in real estate loans		127,001			89,959
Less: Seller financing on sales of real property		(59,649	)		0
Net cash advances on real estate loans receivable		67,352			89,959
Receipts on real estate loans receivable:
Loan payoffs		8,815			29,936
Principal payments on loans		4,586			5,665
Total principal receipts on real estate loans		13,401			35,601
Net cash advances (receipts) on real estate loans receivable	$	53,951		$	54,358

7. Customer Concentration

     At June 30, 2008, we had 69 investment property operators and over 800 medical office building tenants. The following table summarizes certain information about our customer concentration as of June 30, 2008 (dollars in thousands):

	Number of		Total		Percent of
	Properties		Investment		Investment (2)
Concentration by investment (1):
Signature Healthcare LLC		34	$	322,205		6	%
Emeritus Corporation		31		290,054		5	%
Brookdale Senior Living, Inc.		85		289,321		5	%
Senior Living Communities, LLC		9		284,168		5	%
Life Care Centers of America, Inc.		25		261,777		5	%
Remaining portfolio		451		4,027,819		74	%
Totals		635	$	5,475,344		100	%

	Number of		Total		Percent of
	Properties		Revenue (3)		Revenue (4)
Concentration by revenue (1):
Emeritus Corporation		31	$	23,764		9	%
Signature Healthcare LLC		34		19,632		7	%
Brookdale Senior Living, Inc.		85		18,277		7	%
Life Care Centers of America, Inc.		25		12,936		5	%
Lyric Health Care, LLC		27		9,034		3	%
Remaining portfolio		433		189,600		68	%
Other income		n/a		3,601		1	%
Totals		635	$	276,844		100	%

(1)	All of our top five customers are in our investment properties segment.
(2)	Investments with our top five customers comprised 27% of total investments at December 31, 2007.
(3)	Revenues include gross revenues and revenues from discontinued operations for the six months ended June 30, 2008.
(4)	Revenues from our top five customers were 31% for the six months ended June 30, 2007.

11

HEALTH CARE REIT, INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS — Continued

8. Borrowings Under Line of Credit Arrangement and Related Items

     At June 30, 2008, we had an unsecured line of credit arrangement with a consortium of seventeen banks in the amount of $1,150,000,000, which is scheduled to expire on August 5, 2011 (with the ability to extend for one year at our discretion if we are in compliance with all covenants). Borrowings under the agreement are subject to interest payable in periods no longer than three months at either the agent bank’s prime rate of interest or the applicable margin over LIBOR interest rate, at our option (3.08% at June 30, 2008). The applicable margin is based on our ratings with Moody’s Investors Service and Standard & Poor’s Ratings Services and was 0.6% at June 30, 2008. In addition, we pay a facility fee annually to each bank based on the bank’s commitment amount. The facility fee depends on our ratings with Moody’s Investors Service and Standard & Poor’s Ratings Services and was 0.15% at June 30, 2008. We also pay an annual agent’s fee of $50,000. Principal is due upon expiration of the agreement.

     The following information relates to aggregate borrowings under the unsecured line of credit arrangement for the periods presented (dollars in thousands):

	Three Months Ended June 30,						Six Months Ended June 30,
	2008			2007			2008			2007
Balance outstanding at quarter end	$	744,000		$	364,400		$	744,000		$	364,400
Maximum amount outstanding at any month end	$	744,000		$	364,400		$	744,000		$	381,000
Average amount outstanding (total of daily principal balances divided by days in period)	$	542,766		$	270,891		$	474,726		$	257,346
Weighted average interest rate (actual interest expense divided by average borrowings outstanding)		3.54	%		6.78	%		4.05	%		6.71	%

9. Senior Unsecured Notes and Secured Debt

     We have $1,847,555,000 of senior unsecured notes with annual interest rates ranging from 4.75% to 8.00%. The carrying amounts of the senior unsecured notes represent the par value of $1,845,000,000 adjusted for any unamortized premiums or discounts and other basis adjustments related to hedging the debt with derivative instruments. See Note 10 for further discussion regarding derivative instruments. On March 15, 2008, we extinguished $42,330,000 of our 7.625% senior unsecured notes at par upon maturity.

     We have secured debt totaling $465,399,000, collateralized by owned properties, with annual interest rates ranging from 4.89% to 8.08%. The carrying amounts of the secured debt represent the par value of $466,361,000 adjusted for any unamortized fair value adjustments. The carrying values of the properties securing the debt totaled $826,943,000 at June 30, 2008. During the six months ended June 30, 2008, we extinguished six secured debt loans totaling $36,702,000 with a weighted-average interest rate of 6.697% and recognized extinguishment gains of $1,326,000.

     Our debt agreements contain various covenants, restrictions and events of default. Among other things, these provisions require us to maintain certain financial ratios and minimum net worth and impose certain limits on our ability to incur indebtedness, create liens and make investments or acquisitions. As of June 30, 2008, we were in compliance with all of the covenants under our debt agreements.

     At June 30, 2008, the annual principal payments due on these debt obligations are as follows (in thousands):

	Senior		Secured
	Unsecured Notes		Debt		Totals
2008	$	0	$	7,611	$	7,611
2009		0		39,801		39,801
2010		0		15,407		15,407
2011		0		52,620		52,620
2012		250,000		14,039		264,039
Thereafter		1,595,000		336,883		1,931,883
Totals	$	1,845,000	$	466,361	$	2,311,361

12

HEALTH CARE REIT, INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS — Continued

10. Derivative Instruments

     We are exposed to various market risks, including the potential loss arising from adverse changes in interest rates. We may elect to use financial derivative instruments to hedge interest rate exposure. These decisions are principally based on our policy to match our variable rate investments with comparable borrowings, but are also based on the general trend in interest rates at the applicable dates and our perception of the future volatility of interest rates. Derivatives are recorded at fair market value on the balance sheet as assets or liabilities.

     On May 6, 2004, we entered into two interest rate swap agreements (the “2004 Swaps”) for a total notional amount of $100,000,000 to hedge changes in fair value attributable to changes in the LIBOR swap rate of $100,000,000 of fixed rate debt with a maturity date of November 15, 2013. The 2004 Swaps were treated as fair-value hedges for accounting purposes and we utilized the short-cut method to assess effectiveness. The 2004 Swaps were with highly rated counterparties in which we received a fixed rate of 6.0% and paid a variable rate based on six-month LIBOR plus a spread. For the three and six months ended June 30, 2007, we incurred $51,000 and $50,000, respectively, of losses related to the 2004 Swaps that was recorded as an addition to interest expense. On September 12, 2007, we terminated the 2004 Swaps and we received a $2,125,000 cash settlement. The unamortized amount of this settlement at June 30, 2008 was $1,804,000 and is recorded as an adjustment to the hedged debt. This amount will be amortized to interest expense over the life of the hedged debt using the effective interest method. For the three and six months ended June 30, 2008, $84,000 and $169,000, respectively, of amortization was recognized as a reduction to senior unsecured notes interest expense.

     On July 2, 2007, we entered into two forward-starting interest rate swaps (the “July 2007 Swaps”), with an aggregate notional amount of $200,000,000 that were designated as cash flow hedges of the variability in forecasted interest payments attributable to changes in the LIBOR swap rate, on long-term fixed rate debt forecasted to be issued in 2007. The July 2007 Swaps had the economic effect of fixing $200,000,000 of our debt at 4.913% for five years. The July 2007 Swaps were settled on July 17, 2007, which was the date that the forecasted debt was priced. The cash settlement value of these contracts at July 17, 2007 was $733,000. This amount represented the effective portion of the hedges as there was no hedge ineffectiveness. Therefore, the $733,000 settlement value was deferred in accumulated other comprehensive income (“AOCI”) and will be amortized to interest expense using the effective interest method. The unamortized amount of AOCI related to these contracts at June 30, 2008 is $594,000. For the three and six months ended June 30, 2008, we reclassified $37,000 and $74,000, respectively, out of AOCI as a reduction of interest expense.

     On September 12, 2007, we entered into two forward-starting interest rate swaps (the “September 2007 Swaps”) for a total notional amount of $250,000,000 to hedge 10 years of interest payments associated with a long-term borrowing that is expected to occur in 2008. The September 2007 Swaps each have an effective date of September 12, 2008 and a maturity date of September 12, 2018. We expect to settle the September 2007 Swaps when the forecasted debt is priced. The September 2007 Swaps have the economic effect of fixing $250,000,000 of our future debt at 4.469% plus a credit spread for 10 years. The September 2007 Swaps have been designated as cash flow hedges and we expect the September 2007 Swaps to be highly effective at offsetting changes in cash flows of interest payments on $250,000,000 of our future debt due to changes in the LIBOR swap rate. Therefore, effective changes in the fair value of the September 2007 Swaps will be recorded in AOCI and reclassified to interest expense when the hedged forecasted transactions affect earnings (as interest payments are made on the expected debt issuance). The ineffective portion of the changes in fair value will be recorded directly in earnings. At June 30, 2008, the September 2007 Swaps were reported at their fair value of negative $8,486,000 and are included in other liabilities and AOCI as there was no hedge ineffectiveness.

     The valuation of derivative instruments requires us to make estimates and judgments that affect the fair value of the instruments. Fair values for our derivatives are estimated by a third party consultant, which utilizes pricing models that consider forward yield curves and discount rates. Such amounts and the recognition of such amounts are subject to significant estimates that may change in the future.

11. Commitments and Contingencies

     We have an outstanding letter of credit issued for the benefit of certain insurance companies that provide workers’ compensation insurance to one of our tenants. Our obligation to provide the letter of credit terminates in 2009. At June 30, 2008, our obligation under the letter of credit was $2,350,000.

     We have an outstanding letter of credit issued for the benefit of certain insurance companies that provide liability and property insurance to one of our tenants. Our obligation to provide the letter of credit terminates in 2013. At June 30, 2008, our obligation under the letter of credit was $1,000,000.

13

HEALTH CARE REIT, INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS — Continued

     We have an outstanding letter of credit issued for the benefit of a village in Illinois that secures the completion and installation of certain public improvements by one of our tenants in connection with the development of a property. Our obligation to provide the letter of credit terminates in 2010. At June 30, 2008, our obligation under the letter of credit was $679,320.

     We have an outstanding letter of credit issued for the benefit of a municipality in Pennsylvania in connection with the completion and installation of certain property improvements by one of our subsidiaries. The improvements are expected to be completed in 2009. At June 30, 2008, our obligation under the letter of credit was $485,810.

     At June 30, 2008, we had outstanding construction financings of $369,833,000 for leased properties and were committed to providing additional financing of approximately $848,200,000 to complete construction. At June 30, 2008, we had contingent purchase obligations totaling $21,939,000. These contingent purchase obligations primarily relate to deferred acquisition fundings and capital improvements. Deferred acquisition fundings are contingent upon an operator satisfying certain conditions such as payment coverage and value tests. Rents due from the tenant are increased to reflect the additional investment in the property.

     At June 30, 2008, we had operating lease obligations of $159,480,000 relating to certain ground leases and Company office space. We incurred rental expense relating to our Company office space of $267,000 and $544,000 for the three and six months ended June 30, 2008, respectively, and $128,000 and $226,000 for the same periods in 2007. Regarding the ground leases, we have sublease agreements with certain of our operators that require the operators to reimburse us for our monthly operating lease obligations. At June 30, 2008, aggregate future minimum rentals to be received under these noncancelable subleases totaled $31,771,000.

     At June 30, 2008, future minimum lease payments due under operating leases are as follows (in thousands):

2008	$	2,424
2009		4,143
2010		4,046
2011		4,059
2012		4,132
Thereafter		140,676
Totals	$	159,480

12. Stockholders’ Equity

Preferred Stock

     During the six months ended June 30, 2008, certain holders of our Series G Cumulative Convertible Preferred Stock converted 830,350 shares into 594,272 shares of our common stock, leaving 973,850 of such shares outstanding at June 30, 2008.

Common Stock

     The following is a summary of our common stock issuances during the six months ended June 30, 2008 and 2007 (dollars in thousands, except per share amounts):

	Shares Issued		Average Price		Gross Proceeds		Net Proceeds
April 2007 public issuance		6,325,000	$	44.01	$	278,363	$	265,618
2007 Dividend reinvestment plan issuances		787,382		43.64		34,362		34,362
2007 Option exercises		349,437		28.19		9,850		9,850
2007 Totals		7,461,819			$	322,575	$	309,830
March 2008 public issuance		3,000,000	$	41.44	$	124,320	$	118,555
2008 Dividend reinvestment plan issuances		812,815		43.63		35,461		35,461
2008 Option exercises		103,607		29.71		3,078		3,078
2008 Totals		3,916,422			$	162,859	$	157,094

14

HEALTH CARE REIT, INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS — Continued

     On February 20, 2008, we paid a dividend of $0.66 per share to stockholders of record on January 31, 2008. These dividends related to the period from October 1, 2007 through December 31, 2007.

     On May 20, 2008, we paid a dividend of $0.68 per share to stockholders of record on May 2, 2008. These dividends related to the period from January 1, 2008 through March 31, 2008.

Accumulated Other Comprehensive Income

     The following is a summary of accumulated other comprehensive income as of the dates indicated (in thousands):

	June 30, 2008			December 31, 2007
Fair value of cash flow hedges	$	(7,770	)	$	(7,194	)
Unrecognized gains (losses) on equity investments		(781	)		(192	)
Unrecognized actuarial gains (losses)		5			5
Totals	$	(8,546	)	$	(7,381	)

     Please see Note 10 for a discussion of our cash flow hedge activity. We did not recognize any comprehensive income other than the recorded net income for the three and six months ended June 30, 2007.

Other Equity

     Other equity consists of accumulated option compensation expense which represents the amount of amortized compensation costs related to stock options awarded to employees and directors subsequent to January 1, 2003. Expense, which is recognized as the options vest based on the market value at the date of the award, totaled $237,000 and $934,000 for the three and six months ended June 30, 2008, respectively, and $188,000 and $729,000 for the same periods in 2007.

13. Stock Incentive Plans

     Our 2005 Long-Term Incentive Plan authorizes up to 2,200,000 shares of common stock to be issued at the discretion of the Compensation Committee of the Board of Directors. The 2005 Plan replaced the 1995 Stock Incentive Plan and the Stock Plan for Non-Employee Directors. The options granted to officers and key employees under the 1995 Plan continue to vest through 2010 and expire ten years from the date of grant. Our non-employee directors, officers and key employees are eligible to participate in the 2005 Plan. The 2005 Plan allows for the issuance of, among other things, stock options, restricted stock, deferred stock units and dividend equivalent rights. Vesting periods for options, deferred stock units and restricted shares generally range from three years for non-employee directors to five years for officers and key employees. Options expire ten years from the date of grant.

Valuation Assumptions

     The fair value of each option grant is estimated on the date of grant using the Black-Scholes-Merton option pricing model with the following weighted-average assumptions:

	Six Months Ended			Six Months Ended
	June 30, 2008			June 30, 2007
Dividend yield (1)		6.47	%		5.60	%
Expected volatility		20.5	%		19.9	%
Risk-free interest rate		3.42	%		4.74	%
Expected life (in years)		6.5			5
Weighted-average fair value (1)	$	6.25		$	8.31

(1) Certain options granted to employees include dividend equivalent rights (“DERs”). The fair value of options with DERs also includes the net present value of projected future dividend payments over the expected life of the option discounted at the dividend yield rate.

     The dividend yield represented the dividend yield of our common stock on the dates of grant. Our computation of expected volatility was based on historical volatility. The risk-free interest rates used were the 7-year U.S. Treasury Notes yield on the date of grant for the 2008 grants and the 5-year U.S. Treasury Notes yield on the date of grant for the 2007 grants. The expected life was based on historical experience of similar awards, giving consideration to the contractual terms, vesting schedules and expectations regarding future employee behavior.

15

HEALTH CARE REIT, INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS — Continued

Option Award Activity

     The following table summarizes information about stock option activity for the six months ended June 30, 2008:

	Number
	of			Weighted		Weighted Average		Aggregate
	Shares			Average		Remaining		Intrinsic
Stock Options	(000’s)			Exercise Price		Contract Life (years)		Value ($000’s)
Options at beginning of year		637		$	35.54		8.0
Options granted		307			40.83
Options exercised		(104	)		30.04
Options terminated		(8	)		42.00
Options at end of period		832		$	38.11		8.2	$	4,816
Options exercisable at end of period		296		$	33.66		6.3	$	3,036
Weighted average fair value of options granted during the period				$	6.25

     The aggregate intrinsic value is calculated as the difference between the exercise price of the underlying options and the quoted price of our common stock for the options that were in-the-money at June 30, 2008. During the six months ended June 30, 2008, the aggregate intrinsic value of options exercised under our stock incentive plans was $1,755,000 determined as of the date of option exercise. During the six months ended June 30, 2007, the aggregate intrinsic value of options exercised under our stock incentive plans was $5,628,000 determined as of the date of option exercise. Cash received from option exercises under our stock incentive plans for the six months ended June 30, 2008 was $3,078,000. Cash received from option exercises under our stock incentive plans for the six months ended June 30, 2007 was $9,850,000.

     As of June 30, 2008, there was approximately $2,533,000 of total unrecognized compensation cost related to unvested stock options granted under our stock incentive plans. That cost is expected to be recognized over a weighted average period of four years. As of June 30, 2008, there was approximately $11,200,000 of total unrecognized compensation cost related to unvested restricted stock granted under our stock incentive plans. That cost is expected to be recognized over a weighted average period of three years.

     The following table summarizes information about non-vested stock incentive awards as of June 30, 2008 and changes for the six months ended June 30, 2008:

	Stock Options					Restricted Stock
	Number of			Weighted Average		Number of			Weighted Average
	Shares			Grant Date		Shares			Grant Date
	(000’s)			Fair Value		(000’s)			Fair Value
Non-vested at December 31, 2007		382		$	7.20		398		$	40.94
Vested		(147	)		6.02		(98	)		36.52
Granted		307			6.25		159			40.92
Terminated		(8	)		7.04		(4	)		42.11
Non-vested at June 30, 2008		534		$	6.98		455		$	41.88

16

HEALTH CARE REIT, INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS — Continued

14. Earnings Per Share

     The following table sets forth the computation of basic and diluted earnings per share (in thousands, except per share data):

	Three Months Ended				Six Months Ended
	June 30,				June 30,
	2008		2007		2008		2007
Numerator for basic and diluted earnings per share — net income available to common stockholders	$	156,613	$	25,620	$	187,065	$	48,976
Denominator for basic earnings per share — weighted average shares		89,294		79,060		87,698		76,159
Effect of dilutive securities:
Employee stock options		104		98		70		167
Non-vested restricted shares		455		388		455		388
Dilutive potential common shares		559		486		525		555
Denominator for diluted earnings per share — adjusted weighted average shares		89,853		79,546		88,223		76,714
Basic earnings per share	$	1.75	$	0.32	$	2.13	$	0.64
Diluted earnings per share	$	1.74	$	0.32	$	2.12	$	0.64

     The diluted earnings per share calculation excludes the dilutive effect of 0 and 121,000 stock options for the three and six months ended June 30, 2008, respectively, because the exercise prices were greater than the average market price. The diluted earnings per share calculation excludes the dilutive effect of 124,000 stock options for the three and six months ended June 30, 2007, respectively, because the exercise prices were greater than the average market price. The Series E Cumulative Convertible and Redeemable Preferred Stock, the Series G Cumulative Convertible Preferred Stock, the $345,000,000 senior unsecured convertible notes due December 2026 and the $400,000,000 senior unsecured convertible notes due July 2027 were not included in these calculations as the effect of the conversions into common stock was anti-dilutive for the relevant periods presented.

15. Segment Reporting

     We invest in senior housing and health care real estate. We evaluate our business and make resource allocations on our two business segments — investment properties and medical office buildings. Under the investment property segment, we invest in senior housing and health care real estate through acquisition and financing of primarily single tenant properties. Properties acquired are primarily leased under triple-net leases and we are not involved in the management of the property. Our primary investment property types include skilled nursing facilities, assisted living facilities, independent living/continuing care retirement communities and specialty care facilities. Under the medical office building segment, our properties are typically leased under gross leases, modified gross leases or triple-net leases, to multiple tenants, and generally require a certain level of property management. The accounting policies of the segments are the same as those described in the summary of significant accounting policies (see Note 1 to our Annual Report on Form 10-K for the year ended December 31, 2007). There are no intersegment sales or transfers. We evaluate performance based upon net operating income of the combined properties in each segment.

     Non-segment revenue consists mainly of interest income on non-real estate investments and other income. Non-segment assets consist of corporate assets including cash, deferred loan expenses and corporate office equipment among others. Non-property specific revenues and expenses are not allocated to individual segments in determining net operating income.

     During the six months ended June 30, 2008, we changed the name of the operating properties segment to medical office buildings and reclassified certain assets and related revenues. Four specialty care facilities that were formerly classified as operating properties have been reclassified to investment properties. Accordingly, we have reclassified the following prior year amounts to be consistent with the current year classification: (i) rental income of $3,896,000; (ii) real estate depreciation/amortization of $1,443,000; and (iii) total assets of $73,400,000. Additionally, we have restated the following prior year non-segment/corporate assets and revenues to be included in the related business segments to be consistent with the current year classification: (i) $2,155,000 of other income has been reclassified to investment properties; (ii) $74,492,000 of total assets have been reclassified to investment properties; and (iii) $26,066,000 of total assets have been reclassified to medical office buildings.

17

HEALTH CARE REIT, INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS — Continued

     Summary information for the reportable segments during the three months ended June 30, 2008 and 2007 is as follows (in thousands):

									Property		Net		Real Estate
	Rental		Interest		Other		Total		Operating		Operating		Depreciation/		Interest		Total
	Income (1)		Income		Income		Revenues (1)		Expenses		Income (2)		Amortization (1)		Expense (1)		Assets
Three months ended June 30, 2008:
Investment Properties	$	96,807	$	9,175	$	1,533	$	107,515			$	107,515	$	26,419	$	1,675	$	4,419,000
Medical Office Buildings		33,003				237		33,240	$	11,375		21,865		13,211		5,314		1,313,505
Non-segment/Corporate						115		115				115				26,210		72,509
	$	129,810	$	9,175	$	1,885	$	140,870	$	11,375	$	129,495	$	39,630	$	33,199	$	5,805,014
Three months ended June 30, 2007:
Investment Properties	$	86,116	$	6,576	$	812	$	93,504			$	93,504	$	25,836	$	2,312	$	3,524,988
Medical Office Buildings		26,181						26,181	$	8,657		17,524		9,711		5,568		1,228,350
Non-segment/Corporate						332		332				332				25,744		71,466
	$	112,297	$	6,576	$	1,144	$	120,017	$	8,657	$	111,360	$	35,547	$	33,624	$	4,824,804

     Summary information for the reportable segments during the six months ended June 30, 2008 and 2007 is as follows (in thousands):

									Property		Net		Real Estate
	Rental		Interest		Other		Total		Operating		Operating		Depreciation/		Interest		Total
	Income (1)		Income		Income		Revenues (1)		Expenses		Income (2)		Amortization (1)		Expense (1)		Assets
Six months ended June 30, 2008:
Investment Properties	$	188,740	$	18,267	$	2,829	$	209,836			$	209,836	$	52,828	$	3,649	$	4,419,000
Operating Properties		66,236				447		66,683	$	22,742		43,941		26,375		10,880		1,313,505
Non-segment/Corporate					$	325		325				325				53,016		72,509
	$	254,976	$	18,267	$	3,601	$	276,844	$	22,742	$	254,102	$	79,203	$	67,545	$	5,805,014
Six months ended June 30, 2007:
Investment Properties	$	168,603	$	11,725	$	2,155	$	182,483			$	182,483	$	50,879	$	4,622	$	3,524,988
Operating Properties		49,861						49,861	$	15,825		34,036		18,529		9,874		1,228,350
Non-segment/Corporate						582		582				582				51,128		71,466
	$	218,464	$	11,725	$	2,737	$	232,926	$	15,825	$	217,101	$	69,408	$	65,624	$	4,824,804

(1)

Includes amounts from discontinued operations.

(2)

Net operating income (“NOI”) is used to evaluate the operating performance of our properties. We define NOI as total revenues, including tenant reimbursements, less property level operating expenses, which exclude depreciation and amortization, general and administrative expenses, impairments and interest expense. We believe NOI provides investors relevant and useful information because it measures the operating performance of our properties at the property level on an unleveraged basis. We use NOI to make decisions about resource allocations and to assess the property level performance of our properties.

18

HEALTH CARE REIT, INC.
NOTES TO UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS — Continued

16. Supplemental Cash Flow Information

	Six Months Ended
	June 30,
	2008		2007
	(In thousands)
Supplemental cash flow information:
Interest paid	$	79,388	$	71,181
Income taxes paid		1,568		108
Supplemental schedule of non-cash activites:
Assets and liabilities assumed from real property acquisitions:
Secured debt	$	0	$	0
Other liabilities		967		0
Other assets		0		0
Assets and liabilities assumed from business combinations:
Real estate investments	$	0	$	292,067
Other assets acquired		0		6,046
Secured debt		0		146,457
Other liabilities		0		9,693

17. Income Taxes

     During the three months ended December 31, 2007, we recognized $3,900,000 of additional other income related to the payoff of a warrant equity investment. During the three months ended March 31, 2008, we determined that $1,325,000 of income taxes were due in connection with that investment gain.

18. Subsequent Events

Common Stock Issuance

     On July 7, 2008, we completed the issuance of 4,600,000 shares of common stock. We generated net proceeds of approximately $193,041,500.

19

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

     The following discussion and analysis is based primarily on the consolidated financial statements of Health Care REIT, Inc. for the periods presented and should be read together with the notes thereto contained in this Quarterly Report on Form 10-Q. Other important factors are identified in our Annual Report on Form 10-K for the year ended December 31, 2007, as updated by our Current Report on Form 8-K filed June 27, 2008, including factors identified under the headings “Business,” “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations.”

Executive Summary

Company Overview

     Health Care REIT, Inc. is an equity real estate investment trust (“REIT”) that invests in senior housing and health care real estate. Founded in 1970, we were the first REIT to invest exclusively in health care facilities. The following table summarizes our portfolio as of June 30, 2008:

	Investments		Percentage of			Number of		# Beds/Units			Investment per
Type of Property	(in thousands)		Investments			Properties		or Sq. Ft.			metric (1)			States
Independent living/CCRCs	$	950,059		17	%		62		7,684	units	$	161,265	per unit		20
Assisted living facilities		1,128,597		21	%		194		11,810	units		111,649	per unit		31
Skilled nursing facilities		1,579,183		29	%		225		30,464	beds		52,360	per bed		28
Specialty care facilities		533,178		10	%		28		1,885	beds		388,198	per bed		12
Medical office buildings		1,284,327		23	%		126		5,342,072	sq. ft.		269	per sq. ft.		20
Totals	$	5,475,344		100	%		635

(1) Investment per metric was computed by using the total committed investment amount of $6,323,544,000, which includes net real estate investments and unfunded construction commitments for which initial funding has commenced which amounted to $5,475,344,000 and $848,200,000, respectively.

Health Care Industry

     The demand for health care services, and consequently health care properties, is projected to reach unprecedented levels in the near future. The Centers for Medicare and Medicaid Services projects that national health expenditures will rise to $3.8 trillion in 2015 or 18.8% of gross domestic product (“GDP”). This is up from $2 trillion or 15.9% of GDP in 2005. Health expenditures per capita are projected to rise 5.8% per year from 2005 to 2015. While demographics are the primary driver of demand, economic conditions and availability of services contribute to health care service utilization rates. We believe the health care property market is less susceptible to fluctuations and economic downturns relative to other property sectors. Investor interest in the market remains strong, especially in specific sectors such as medical office buildings, regardless of the current stringent lending environment. As a REIT, we believe we are situated to benefit from any turbulence in the capital markets due to our access to capital.

     The total U.S. population is projected to increase by 20% through 2030. The elderly are an important component of health care utilization, especially independent living services, assisted living services, skilled nursing services, inpatient and outpatient hospital services and physician ambulatory care. The elderly population aged 65 and over is projected to increase by 85% through 2030. Most health care services are provided within a health care facility such as a hospital, a physician’s office or a senior housing facility. Therefore, we believe there will be continued demand for companies such as ours with expertise in health care real estate.

20

     The following chart illustrates the projected increase in the elderly population aged 65 and over:

65+ Population and % of Total

     Source: U.S. Census Bureau

     Health care real estate investment opportunities tend to increase as demand for health care services increases. We recognize the need for health care real estate as it correlates to health care service demand. Health care providers require real estate to house their businesses and expand their services. We believe that investment opportunities in health care real estate will continue to be present due to the:

• Specialized nature of the industry which enhances the credibility and experience of our company;

• Projected population growth combined with stable or increasing health care utilization rates which ensures demand; and

• On-going merger and acquisition activity.

Business Strategy

     Our primary objectives are to protect stockholder capital and enhance stockholder value. We seek to pay consistent cash dividends to stockholders and create opportunities to increase dividend payments to stockholders as a result of annual increases in rental and interest income and portfolio growth. To meet these objectives, we invest across a broad spectrum of senior housing and health care real estate and diversify our investment portfolio by property type, operator/tenant and geographic location.

     Substantially all of our revenues and sources of cash flows from operations are derived from operating lease rentals and interest earned on outstanding loans receivable. These items represent our primary source of liquidity to fund distributions and are dependent upon our obligors’ continued ability to make contractual rent and interest payments to us. To the extent that our obligors experience operating difficulties and are unable to generate sufficient cash to make payments to us, there could be a material adverse impact on our consolidated results of operations, liquidity and/or financial condition. To mitigate this risk, we monitor our investments through a variety of methods determined by the type of property and operator/tenant. Our asset management process includes review of monthly financial statements, periodic review of obligor credit, periodic property inspections and review of covenant compliance relating to licensure, real estate taxes, letters of credit and other collateral. In monitoring our portfolio, our personnel use a proprietary database to collect and analyze property-specific data. Additionally, we conduct extensive research to ascertain industry trends and risks. Through these asset management and research efforts, we are typically able to intervene at an early stage to address payment risk, and in so doing, support both the collectibility of revenue and the value of our investment.

     With respect to our investment properties, we also structure our investments to help mitigate payment risk. Operating leases and loans are normally credit enhanced by guaranties and/or letters of credit. In addition, operating leases are typically structured as master leases and loans are generally cross-defaulted and cross-collateralized with other loans, operating leases or agreements between us and the obligor and its affiliates.

     For the six months ended June 30, 2008, rental income and interest income represented 92% and 7%, respectively, of total gross revenues (including revenues from discontinued operations). Substantially all of our operating leases are designed with either fixed or contingent escalating rent structures. Leases with fixed annual rental escalators are generally recognized on a straight-line basis over the initial lease period, subject to a collectibility assessment. Rental income related to leases with contingent rental escalators is generally recorded based on the contractual cash rental payments due for the period. Our yield on loans receivable depends upon a number of factors, including the stated interest rate, the average principal amount outstanding during the term of the loan and any interest rate adjustments.

21

     Depending upon the availability and cost of external capital, we anticipate investing in additional properties. New investments are generally funded from temporary borrowings under our unsecured line of credit arrangement, internally generated cash and the proceeds from sales of real property. Our investments generate internal cash from rent and interest receipts and principal payments on loans receivable. Permanent financing for future investments, which replaces funds drawn under the unsecured line of credit arrangement, is expected to be provided through a combination of public and private offerings of debt and equity securities and the incurrence or assumption of secured debt. We believe our liquidity and various sources of available capital are sufficient to fund operations, meet debt service obligations (both principal and interest), make dividend distributions and finance future investments.

     Depending upon market conditions, we believe that new investments will be available in the future with spreads over our cost of capital that will generate appropriate returns to our stockholders. During the six months ended June 30, 2008, we completed $669,497,000 of gross investments and $133,278,000 of investment payoffs, resulting in $536,219,000 of net new investments. We expect to complete gross new investments of approximately $1.1 billion to $1.4 billion during 2008, including acquisitions of approximately $700,000,000 to $900,000,000 and funded new development of approximately $400,000,000 to $500,000,000. We anticipate the sale of real property and the repayment of loans receivable totaling approximately $300,000,000 to $400,000,000 resulting in net new investments of approximately $700,000,000 to $1.1 billion during 2008. It is possible that additional loan repayments or sales of real property may occur in the future. To the extent that loan repayments and real property sales exceed new investments, our revenues and cash flows from operations could be adversely affected. We expect to reinvest the proceeds from any loan repayments and real property sales in new investments. To the extent that new investment requirements exceed our available cash on hand, we expect to borrow under our unsecured line of credit arrangement. At June 30, 2008, we had $25,078,000 of cash and cash equivalents and $406,000,000 of available borrowing capacity under our unsecured line of credit arrangement.

Key Transactions in 2008

     We have completed the following key transactions to date in 2008:

• our Board of Directors increased our quarterly dividend to $0.68 per share, which represents a two cent increase from the quarterly dividend of $0.66 paid for 2007. The dividend declared for the quarter ended June 30, 2008 represents the 149^th consecutive quarterly dividend payment;

• we completed $669,497,000 of gross investments and had $133,278,000 of investment payoffs during the six months ended June 30, 2008;

• we completed a public offering of 3,000,000 shares of common stock with net proceeds of approximately $118,555,000 in March 2008; and

• we completed a public offering of 4,600,000 shares of common stock with net proceeds of approximately $193,041,500 in July 2008.

Key Performance Indicators, Trends and Uncertainties

     We utilize several key performance indicators to evaluate the various aspects of our business. These indicators are discussed below and relate to operating performance, concentration risk and credit strength. Management uses these key performance indicators to facilitate internal and external comparisons to our historical operating results, in making operating decisions and for budget planning purposes.

     Operating Performance. We believe that net income available to common stockholders (“NICS”) is the most appropriate earnings measure. Other useful supplemental measures of our operating performance include funds from operations (“FFO”) and net operating income (“NOI”); however, these supplemental measures are not defined by U.S. generally accepted accounting principles (“U.S. GAAP”). Please refer to the section entitled “Non-GAAP Financial Measures” for further discussion and reconciliations of FFO and NOI. These earnings measures and their relative per share amounts are widely used by investors and analysts in the valuation, comparison and investment recommendations of companies. The following table reflects the recent historical trends of our operating performance measures for the periods presented (in thousands, except per share data):

22

	Three Months Ended
	March 31,		June 30,		September 30,		December 31,		March 31,		June 30,
	2007		2007		2007		2007		2008		2008
Net income available to common stockholders	$	23,356	$	25,620	$	24,529	$	42,768	$	30,452	$	156,613
Funds from operations		56,207		59,979		63,830		71,099		69,913		77,988
Net operating income		105,741		111,360		115,550		123,029		124,607		129,495
Per share data (fully diluted):
Net income available to common stockholders	$	0.32	$	0.32	$	0.30	$	0.52	$	0.35	$	1.74
Funds from operations		0.76		0.75		0.79		0.86		0.81		0.87

     Credit Strength. We measure our credit strength both in terms of leverage ratios and coverage ratios. Our leverage ratios include debt to book capitalization and debt to market capitalization. The leverage ratios indicate how much of our balance sheet capitalization is related to long-term debt. The coverage ratios indicate our ability to service interest and fixed charges (interest, secured debt principal amortization and preferred dividends). We expect to maintain capitalization ratios and coverage ratios sufficient to maintain investment grade ratings with Moody’s Investors Service, Standard & Poor’s Ratings Services and Fitch Ratings. The coverage ratios are based on earnings before interest, taxes, depreciation and amortization (“EBITDA”) which is discussed in further detail, and reconciled to net income, below in “Non-GAAP Financial Measures.” Leverage ratios and coverage ratios are widely used by investors, analysts and rating agencies in the valuation, comparison, investment recommendations and rating of companies. The following table reflects the recent historical trends for our credit strength measures for the periods presented:

	Three Months Ended
	March 31,			June 30,			September 30,			December 31,			March 31,			June 30,
	2007			2007			2007			2007			2008			2008
Debt to book capitalization ratio		54	%		52	%		53	%		53	%		52	%		54	%
Debt to undepreciated book capitalization ratio		50	%		48	%		49	%		48	%		48	%		49	%
Debt to market capitalization ratio		40	%		41	%		40	%		39	%		39	%		41	%
Interest coverage ratio		2.82	x		2.83	x		2.81	x		3.17	x		2.87	x		6.19	x
Fixed charge coverage ratio		2.28	x		2.30	x		2.31	x		2.62	x		2.38	x		5.17	x

     Concentration Risk. We evaluate our concentration risk in terms of asset mix, investment mix, customer mix and geographic mix. Concentration risk is a valuable measure in understanding what portion of our investments could be at risk if certain sectors were to experience downturns. Asset mix measures the portion of our investments that are real property. In order to qualify as an equity REIT, at least 75% of our real estate investments must be real property whereby each property, which includes the land, buildings, improvements, intangibles and related rights, is owned by us and leased to a tenant pursuant to a long-term operating lease. Investment mix measures the portion of our investments that relate to our various property types. Customer mix measures the portion of our investments that relate to our top five customers. Geographic mix measures the portion of our investments that relate to our top five states. The following table reflects our recent historical trends of concentration risk for the periods presented:

23

	March 31,			June 30,			September 30,			December 31,			March 31,			June 30,
	2007			2007			2007			2007			2008			2008
Asset mix:
Real property		94	%		95	%		94	%		92	%		92	%		91	%
Real estate loans receivable		6	%		5	%		6	%		8	%		8	%		9	%
Investment mix:
Independent living/CCRCs		13	%		13	%		14	%		15	%		16	%		17	%
Assisted living facilities		24	%		22	%		21	%		21	%		21	%		21	%
Skilled nursing facilities		36	%		33	%		32	%		32	%		31	%		29	%
Specialty care facilities		6	%		6	%		7	%		7	%		7	%		10	%
Medical office buildings		21	%		26	%		26	%		25	%		25	%		23	%
Customer mix:
Signature Healthcare LLC											6	%		6	%		6	%
Emeritus Corporation		8	%		8	%		7	%		7	%		7	%		5	%
Brookdale Senior Living Inc.		7	%		6	%		5	%		5	%		5	%		5	%
Senior Living Communities, LLC											4	%		4	%		5	%
Life Care Centers of America, Inc.		6	%		5	%		5	%		5	%		5	%		5	%
Home Quality Management, Inc.		6	%		5	%		5	%
Merrill Gardens L.L.C.		4	%		4	%		4	%
Remaining customers		69	%		72	%		74	%		73	%		73	%		74	%
Geographic mix:
Florida		16	%		16	%		16	%		15	%		15	%		14	%
Texas		13	%		13	%		13	%		13	%		13	%		12	%
California		7	%		7	%		7	%		7	%		7	%		8	%
Massachusetts		8	%		7	%		7	%		7	%		7	%		7	%
Tennessee											6	%		6	%		6	%
Ohio		6	%		6	%		6	%
Remaining states		50	%		51	%		51	%		52	%		52	%		53	%

     We evaluate our key performance indicators in conjunction with current expectations to determine if historical trends are indicative of future results. Our expected results may not be achieved and actual results may differ materially from our expectations. Factors that may cause actual results to differ from expected results are described in more detail in “Forward-Looking Statements and Risk Factors” and other sections of this Quarterly Report on Form 10-Q. Management regularly monitors economic and other factors to develop strategic and tactical plans designed to improve performance and maximize our competitive position. Our ability to achieve our financial objectives is dependent upon our ability to effectively execute these plans and to appropriately respond to emerging economic and company-specific trends. Please refer to our Annual Report on Form 10-K for the year ended December 31, 2007, as updated by our Current Report on Form 8-K filed June 27, 2008, under the headings “Business,” “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” for further discussion of these risk factors.

Portfolio Update

     Net operating income. The primary performance measure for our properties is net operating income (“NOI”) as discussed below in “Non-GAAP Financial Measures.” The following table summarizes our net operating income for the periods indicated (in thousands):

	Three Months Ended
	March 31,		June 30,		September 30,		December 31,		March 31,		June 30,
	2007		2007		2007		2007		2008		2008
Net operating income:
Investment properties	$	88,980	$	93,504	$	94,538	$	102,495	$	102,321	$	107,515
Medical office buildings		16,512		17,524		20,450		20,150		22,076		21,865
Non-segment/corporate		249		332		562		384		210		115
Net operating income	$	105,741	$	111,360	$	115,550	$	123,029	$	124,607	$	129,495

     Payment coverage. Payment coverage of the operators in our investment property portfolio continues to remain strong. Our overall payment coverage is at 1.98 times, which represents an improvement of two basis points from the prior year. The table below reflects our recent historical trends of portfolio coverage. Coverage data reflects the 12 months ended for the periods presented. CBMF represents the ratio of our customers’ earnings before interest, taxes, depreciation, amortization, rent and management fees to contractual

24

rent or interest due us. CAMF represents the ratio of our customers’ earnings before interest, taxes, depreciation, amortization and rent (but after imputed management fees) to contractual rent or interest due us.

March 31, 2006

March 31, 2007

March 31, 2008

CBMF

CAMF

CBMF

CAMF

CBMF

CAMF

Independent living/CCRCs

1.47x

1.25x

1.42x

1.22x

1.39x

1.18x

Assisted living facilities

1.53x

1.31x

1.59x

1.38x

1.58x

1.35x

Skilled nursing facilities

2.16x

1.58x

2.20x

1.58x

2.28x

1.67x

Specialty care facilities

3.02x

2.42x

2.64x

2.09x

2.52x

1.96x

Weighted averages

1.93x

1.51x

1.96x

1.52x

1.98x

1.54x

Corporate Governance

     Maintaining investor confidence and trust has become increasingly important in today’s business environment. Health Care REIT, Inc.’s Board of Directors and management are strongly committed to policies and procedures that reflect the highest level of ethical business practices. Our corporate governance guidelines provide the framework for our business operations and emphasize our commitment to increase stockholder value while meeting all applicable legal requirements. In March 2004, the Board of Directors adopted its Corporate Governance Guidelines. These guidelines meet the listing standards adopted by the New York Stock Exchange and are available on our website at www.hcreit.com and from us upon written request sent to the Senior Vice President - Administration and Corporate Secretary, Health Care REIT, Inc., One SeaGate, Suite 1500, P.O. Box 1475, Toledo, Ohio 43603-1475.

Liquidity and Capital Resources

Sources and Uses of Cash

     Our primary sources of cash include rent and interest receipts, borrowings under the unsecured line of credit arrangement, public and private offerings of debt and equity securities, proceeds from the sales of real property and principal payments on loans receivable. Our primary uses of cash include dividend distributions, debt service payments (including principal and interest), real property investments (including construction advances), loan advances and general and administrative expenses. These sources and uses of cash are reflected in our Consolidated Statements of Cash Flows and are discussed in further detail below.

     The following is a summary of our sources and uses of cash flows (dollars in thousands):

	Six Months Ended						Change
	June 30, 2008			June 30, 2007			$			%
Cash and cash equivalents at beginning of period	$	30,269		$	36,216		$	(5,947	)		-16	%
Cash provided from (used in) operating activities		166,429			118,935			47,494			40	%
Cash provided from (used in) investing activities		(552,240	)		(452,349	)		(99,891	)		22	%
Cash provided from (used in) financing activities		380,620			335,670			44,950			13	%
Cash and cash equivalents at end of period	$	25,078		$	38,472		$	(13,394	)		-35	%

     Operating Activities. The change in net cash provided from operating activities is primarily attributable to an increase in net income, excluding gains on sales of properties and depreciation and amortization. The increase in net income is discussed below in “Results of Operations.”

     The following is a summary of our straight-line rent and above/below market lease amortization (dollars in thousands):

	Six Months Ended						Change
	June 30, 2008			June 30, 2007			$			%
Gross straight-line rental income	$	10,370		$	8,109		$	2,261			28	%
Cash receipts due to real property sales		(1,595	)		0			(1,595	)		n/a
Prepaid rent receipts		(9,303	)		(4,910	)		(4,393	)		89	%
Amortization related to above (below) market leases, net		462			924			(462	)		-50	%
	$	(66	)	$	4,123		$	(4,189	)		n/a

     Gross straight-line rental income represents the non-cash difference between contractual cash rent due and the average rent recognized pursuant to Statement of Financial Accounting Standards No. 13, Accounting for Leases (“SFAS 13”), for leases with fixed rental escalators, net of collectibility reserves. This amount is positive in the first half of a lease term (but declining every year due to annual increases in cash rent due) and is negative in the second half of a lease term. The increase in gross straight-line rental income is

25

primarily due to an increase in the number of leases with fixed annual increases resulting from medical office building acquisitions completed subsequent to June 30, 2007. The fluctuation in cash receipts due to real property sales is attributable to the lack of straight-line rent receivable balances on properties sold during the six months ended June 30, 2007. The increase in prepaid rent receipts is primarily due to the mix of real property acquisitions during the periods presented. We typically receive prepaid rent in connection with investment property acquisitions. As discussed below in “Investing Activities,” we had investment property acquisitions totaling $266,090,000 during the six months ended June 30, 2008 as compared to $131,225,000 for the same period in 2007.

     Investing Activities. The changes in net cash used in investing activities are primarily attributable to net changes in real property and real estate loans receivable. The following is a summary of our investment and disposition activities (dollars in thousands):

	Six Months Ended
	June 30, 2008						June 30, 2007
	Properties			Amount			Properties		Amount
Real property acquisitions:
Independent living/CCRCs		2		$	68,300				$	0
Assisted living facilities		3			45,490			2		9,875
Skilled nursing facilities					0			7		103,300
Specialty care facilities		4			142,300			1		11,923
Medical office buildings		4			47,853			19		314,175
Land parcels		1			10,000					6,127
Total acquisitions		14			313,943			29		445,400
Less: Assumed debt					0					(146,457	)
Assumed other assets (liabilities), net					(967	)				(3,643	)
Cash disbursed for acquisitions					312,976					295,300
Construction in progress additions					210,495					104,520
Capital improvements to existing properties					10,507					12,266
Total cash invested in real property					533,978					412,086
Real property dispositions:
Independent living/CCRCs		2			15,547					0
Assisted living facilities		19			105,244			3		14,796
Skilled nursing facilities		2			3,672			1		4,304
Land parcels					73					3,073
Total dispositions		23			124,536			4		22,173
Less: Gain/(loss) on sales of real property					118,194					2,010
Seller financing on sales of real property					(59,649	)				0
Proceeds from real property sales					183,081					24,183
Net cash investments in real property		(9	)	$	350,897			25	$	387,903
Advances on real estate loans receivable:
Investments in new loans				$	117,763				$	76,875
Draws on existing loans					9,238					13,084
Total gross investments in real estate loans					127,001					89,959
Less: Seller financing on sales of real property					(59,649	)				0
Net cash advances on real estate loans receivable					67,352					89,959
Receipts on real estate loans receivable:
Loan payoffs					8,815					29,936
Principal payments on loans					4,586					5,665
Total principal receipts on real estate loans					13,401					35,601
Net cash advances (receipts) on real estate loans receivable				$	53,951				$	54,358

     Financing Activities. The changes in net cash provided from or used in financing activities are primarily attributable to changes related to our long-term debt arrangements, proceeds from the issuance of common stock and dividend payments.

     For the six months ended June 30, 2008, we had a net increase of $437,000,000 on our unsecured line of credit arrangement as compared to a net increase of $139,400,000 for the same period in 2007. On March 15, 2008, we extinguished $42,330,000 of our 7.625% senior unsecured notes at maturity. During the six months ended June 30, 2008, we extinguished six secured debt loans totaling $36,702,000 with a weighted-average interest rate of 6.697% and recognized extinguishment gains of $1,326,000.

     The following is a summary of our common stock issuances (dollars in thousands, except per share amounts):

26

	Shares Issued		Average Price		Gross Proceeds		Net Proceeds
April 2007 public issuance		6,325,000	$	44.01	$	278,363	$	265,618
2007 Dividend reinvestment plan issuances		787,382		43.64		34,362		34,362
2007 Option exercises		349,437		28.19		9,850		9,850
2007 Totals		7,461,819			$	322,575	$	309,830
March 2008 public issuance		3,000,000	$	41.44	$	124,320	$	118,555
2008 Dividend reinvestment plan issuances		812,815		43.63		35,461		35,461
2008 Option exercises		103,607		29.71		3,078		3,078
2008 Totals		3,916,422			$	162,859	$	157,094

     In order to qualify as a REIT for federal income tax purposes, we must distribute at least 90% of our taxable income (including 100% of capital gains) to our stockholders. The increase in dividends is primarily attributable to an increase in our common stock outstanding and the payment of prorated dividends of $0.2991 per common share in February 2007 due to the prorated dividend payment of $0.3409 per common share in December 2006 in conjunction with the Windrose merger.

     The following is a summary of our dividend payments (in thousands, except per share amounts):

	Six Months Ended
	June 30, 2008				June 30, 2007
	Per Share		Amount		Per Share		Amount
Common Stock	$	1.3400	$	118,411	$	0.9591	$	75,524
Series D Preferred Stock		0.9844		3,938		0.9844		3,937
Series E Preferred Stock		0.7500		56		0.7500		56
Series F Preferred Stock		0.9532		6,672		0.9532		6,672
Series G Preferred Stock		0.9376		1,265		0.9376		1,969
Totals			$	130,342			$	88,158

Off-Balance Sheet Arrangements

     At June 30, 2008, we had four outstanding letter of credit obligations totaling $4,515,130 and expiring between 2009 and 2013. Please see Note 11 to our unaudited consolidated financial statements for additional information.

     We are exposed to various market risks, including the potential loss arising from adverse changes in interest rates. We may or may not elect to use financial derivative instruments to hedge interest rate exposure. These decisions are principally based on the general trend in interest rates at the applicable dates, our perception of the future volatility of interest rates and our relative levels of variable rate debt and variable rate investments. As of June 30, 2008, we participated in two forward-starting interest rate swap agreements related to our long-term debt. Please see Note 10 to our unaudited consolidated financial statements for additional information.

Contractual Obligations

     The following table summarizes our payment requirements under contractual obligations as of June 30, 2008 (in thousands):

	Payments Due by Period
Contractual Obligations	Total		2008		2009-2010		2011-2012		Thereafter
Unsecured line of credit arrangement	$	744,000	$	0	$	0	$	744,000	$	0
Senior unsecured notes (1)		1,845,000		0		0		250,000		1,595,000
Secured debt (1)		466,361		7,611		55,208		66,659		336,883
Contractual interest obligations		1,343,951		79,060		311,333		269,174		684,384
Capital lease obligations		0		0		0		0		0
Operating lease obligations		159,480		2,424		8,189		8,191		140,676
Purchase obligations		870,139		44,217		641,057		184,865		0
Other long-term liabilities		4,190		112		788		3,290		0
Total contractual obligations	$	5,433,121	$	133,424	$	1,016,575	$	1,526,179	$	2,756,943

(1) Amounts represent principal amounts due and do not reflect unamortized premiums/discounts or other fair value adjustments as reflected on the balance sheet.

27

     At June 30, 2008, we had an unsecured line of credit arrangement with a consortium of seventeen banks in the amount of $1.15 billion, which is scheduled to expire on August 5, 2011. Borrowings under the agreement are subject to interest payable in periods no longer than three months at either the agent bank’s prime rate of interest or the applicable margin over LIBOR interest rate, at our option (3.08% at June 30, 2008). The applicable margin is based on our ratings with Moody’s Investors Service and Standard & Poor’s Ratings Services and was 0.6% at June 30, 2008. In addition, we pay a facility fee annually to each bank based on the bank’s commitment amount. The facility fee depends on our ratings with Moody’s Investors Service and Standard & Poor’s Ratings Services and was 0.15% at June 30, 2008. We also pay an annual agent’s fee of $50,000. Principal is due upon expiration of the agreement. At June 30, 2008, we had $744,000,000 outstanding under the unsecured line of credit arrangement and estimated total contractual interest obligations of $70,667,000. Contractual interest obligations are estimated based on the assumption that the balance of $744,000,000 at June 30, 2008 is constant until maturity at interest rates in effect at June 30, 2008.

     We have $1,845,000,000 of senior unsecured notes principal outstanding with fixed annual interest rates ranging from 4.75% to 8%, payable semi-annually. Total contractual interest obligations on senior unsecured notes totaled $1,114,287,000 at June 30, 2008. Additionally, we have secured debt with total outstanding principal of $466,361,000, collateralized by owned properties, with fixed annual interest rates ranging from 4.89% to 8.08%, payable monthly. The carrying values of the properties securing the debt totaled $826,943,000 at June 30, 2008. Total contractual interest obligations on secured debt totaled $158,997,000 at June 30, 2008.

     At June 30, 2008, we had operating lease obligations of $159,480,000 relating primarily to ground leases at certain of our properties and office space leases.

     Purchase obligations are comprised of unfunded construction commitments and contingent purchase obligations. At June 30, 2008, we had outstanding construction financings of $369,833,000 for leased properties and were committed to providing additional financing of approximately $848,200,000 to complete construction. At June 30, 2008, we had contingent purchase obligations totaling $21,939,000. These contingent purchase obligations primarily relate to deferred acquisition fundings and capital improvements. Deferred acquisition fundings are contingent upon a tenant satisfying certain conditions in the lease. Upon funding, amounts due from the tenant are increased to reflect the additional investment in the property.

     Other long-term liabilities relate to our Supplemental Executive Retirement Plan (“SERP”) and certain non-compete agreements. We have a SERP, a non-qualified defined benefit pension plan, which provides certain executive officers with supplemental deferred retirement benefits. The SERP provides an opportunity for participants to receive retirement benefits that cannot be paid under our tax-qualified plans because of the restrictions imposed by ERISA and the Internal Revenue Code of 1986, as amended. Benefits are based on compensation and length of service and the SERP is unfunded. No contributions by the Company are anticipated for the 2008 fiscal year. Benefit payments are expected to total $3,290,000 during the next five fiscal years and no benefit payments are expected to occur during the succeeding five fiscal years. We use a December 31 measurement date for the SERP. The accrued liability on our balance sheet for the SERP was $2,155,000 and $1,915,000 at June 30, 2008 and December 31, 2007, respectively.

     In connection with the Windrose merger, we entered into consulting agreements with Fred S. Klipsch and Frederick L. Farrar, which expire in December 2008 and may be terminated at any time by the consultant. Each consultant has agreed not to compete with the Company for a period of two years following termination or expiration of the agreement. In exchange for complying with the covenant not to compete, Messers. Klipsch and Farrar will receive eight quarterly payments of $75,000 and $37,500, respectively, with the first payment to be made on the date of termination or expiration of the agreement.

Capital Structure

     As of June 30, 2008, we had stockholders’ equity of $2,633,124,000 and a total outstanding debt balance of $3,056,954,000, which represents a debt to total book capitalization ratio of 54%. Our ratio of debt to market capitalization was 41% at June 30, 2008. For the six months ended June 30, 2008, our interest coverage ratio was 4.51 to 1.00. For the six months ended June 30, 2008, our fixed charge coverage ratio was 3.74 to 1.00. Also, at June 30, 2008, we had $25,078,000 of cash and cash equivalents and $406,000,000 of available borrowing capacity under our unsecured line of credit arrangement. In July 2008, we completed a public offering of 4,600,000 shares of common stock with net proceeds of approximately $193,041,500.

     Our debt agreements contain various covenants, restrictions and events of default. Among other things, these provisions require us to maintain certain financial ratios and minimum net worth and impose certain limits on our ability to incur indebtedness, create liens and make investments or acquisitions. As of June 30, 2008, we were in compliance with all of the covenants under our debt agreements. Please refer to the section entitled “Non-GAAP Financial Measures” for further discussion. None of our debt agreements contain provisions for acceleration which could be triggered by our debt ratings with Moody’s Investors Service and Standard & Poor’s Ratings Services. However, under our unsecured line of credit arrangement, these ratings on our senior unsecured notes are used to determine the fees and interest charged.

28

     As of July 31, 2008, our senior unsecured notes were rated Baa2 (stable), BBB- (positive) and BBB (stable) by Moody’s Investors Service, Standard & Poor’s Ratings Services and Fitch Ratings, respectively. We plan to manage the company to maintain investment grade status with a capital structure consistent with our current profile. Any downgrades in terms of ratings or outlook by any or all of the noted rating agencies could have a material adverse impact on our cost and availability of capital, which could in turn have a material adverse impact on our consolidated results of operations, liquidity and/or financial condition.

     On May 12, 2006, we filed an open-ended automatic or “universal” shelf registration statement with the Securities and Exchange Commission covering an indeterminate amount of future offerings of debt securities, common stock, preferred stock, depositary shares, warrants and units. As of July 31, 2008, we had an effective registration statement on file in connection with our enhanced dividend reinvestment plan under which we may issue up to 10,760,247 shares of common stock. As of July 31, 2008, 8,670,452 shares of common stock remained available for issuance under this registration statement. Depending upon market conditions, we anticipate issuing securities under our registration statements to invest in additional properties and to repay borrowings under our unsecured line of credit arrangement.

Results of Operations

     Our primary sources of revenue include rent and interest. Our primary expenses include interest expense, depreciation and amortization, property operating expenses and general and administrative expenses. These revenues and expenses are reflected in our Consolidated Statements of Income and are discussed in further detail below. The following is a summary of our results of operations (dollars in thousands except per share amounts):

	Three Months Ended						Change						Six Months Ended						Change
	June 30, 2008			June 30, 2007			Amount			%			June 30, 2008			June 30, 2007			Amount			%
Net income available to common stockholders	$	156,613		$	25,620		$	130,993			511	%	$	187,065		$	48,976		$	138,089			282	%
Funds from operations		77,988			59,979			18,009			30	%		147,900			116,187			31,713			27	%
EBITDA		237,023			102,275			134,748			132	%		350,591			199,087			151,504			76	%
Net operating income		129,495			111,360			18,135			16	%		254,102			217,101			37,001			17	%
Per share data (fully diluted):
Net income available to common stockholders	$	1.74		$	0.32		$	1.42			444	%	$	2.12		$	0.64		$	1.48			231	%
Funds from operations		0.87			0.75			0.12			16	%		1.68			1.51			0.17			11	%
Interest coverage ratio		6.19	x		2.83	x		3.36	x		119	%		4.51	x		2.82	x		1.69	x		60	%
Fixed charge coverage ratio		5.17	x		2.30	x		2.87	x		125	%		3.74	x		2.29	x		1.45	x		63	%

     We evaluate our business and make resource allocations on our two business segments — investment properties and medical office buildings. Under the investment property segment, properties are primarily leased under triple-net leases and we are not involved in the management of the property. Under the medical office building segment, our properties are typically leased under gross leases, modified gross leases or triple-net leases, to multiple tenants, and generally require a certain level of property management. There are no intersegment sales or transfers. Non-segment revenue consists mainly of interest income on non-real estate investments and other income. Non-property specific revenues and expenses are not allocated to individual segments in determining net operating income. Please see Note 15 to our unaudited consolidated financial statements for additional information.

     Investment Properties

     The following is a summary of our results of operations for the investment properties segment (dollars in thousands):

29

	Three Months Ended				Change						Six Months Ended					Change
	June 30, 2008		June 30, 2007		$			%			June 30, 2008			June 30, 2007		$			%
Revenues:
Rental income	$	91,825	$	78,842	$	12,983			16	%	$	178,632		$	153,780	$	24,852			16	%
Interest income		9,175		6,576		2,599			40	%		18,267			11,725		6,542			56	%
Other income		1,533		812		721			89	%		2,829			2,155		674			31	%
		102,533		86,230		16,303			19	%		199,728			167,660		32,068			19	%
Expenses:
Interest expense		424		380		44			12	%		1,147			599		548			91	%
Depreciation and amortization		25,264		23,567		1,697			7	%		50,499			46,276		4,223			9	%
Gain on extinguishment of debt		0		0		0			n/a			(40	)		0		(40	)		n/a
		25,688		23,947		1,741			7	%		51,606			46,875		4,731			10	%
Income from continuing operations before income taxes		76,845		62,283		14,562			23	%		148,122			120,785		27,337			23	%
Income tax expense		0		293		(293	)		-100	%		(1,351	)		293		(1,644	)		n/a
Income from continuing operations		76,845		62,576		14,269			23	%		146,771			121,078		25,693			21	%
Discontinued operations:
Gain (loss) on sales of properties		118,168		1,033		117,135			11339	%		118,194			2,010		116,184			5780	%
Income (loss) from discontinued operations, net		2,576		3,073		(497	)		-16	%		5,277			6,197		(920	)		-15	%
Discontinued operations, net		120,744		4,106		116,638			2841	%		123,471			8,207		115,264			1404	%
Net income	$	197,589	$	66,682	$	130,907			196	%	$	270,242		$	129,285	$	140,957			109	%

     The increase in rental income is primarily attributable to the acquisitions of new investment properties from which we receive rent. See the discussion of investing activities in “Liquidity and Capital Resources” above for further information. Certain of our leases contain annual rental escalators that are contingent upon changes in the Consumer Price Index and/or changes in the gross operating revenues of the tenant’s properties. These escalators are not fixed, so no straight-line rent is recorded; however, rental income is recorded based on the contractual cash rental payments due for the period. If gross operating revenues at our facilities and/or the Consumer Price Index do not increase, a portion of our revenues may not continue to increase. Sales of real property would offset revenue increases and, to the extent that they exceed new acquisitions, could result in decreased revenues. Our leases could renew above or below current rent rates, resulting in an increase or decrease in rental income. Interest income increased from 2007 primarily due to an increase in the balance of outstanding loans.

     Interest expense for the six months ended June 30, 2008 represents $3,649,000 of secured debt interest expense offset by $2,502,000 of interest allocated to discontinued operations. Interest expense for the six months ended June 30, 2007 represents $4,622,000 of secured debt interest expense offset by $4,023,000 of interest allocated to discontinued operations. The change in secured debt interest expense is due to the net effect and timing of assumptions, extinguishments and principal amortizations. During the six months ended June 30, 2008, we extinguished three investment property secured debt loans and recognized extinguishment gains of $40,000. The following is a summary of our investment property secured debt principal activity (dollars in thousands):

	Three Months Ended						Three Months Ended						Six Months Ended						Six Months Ended
	June 30, 2008						June 30, 2007						June 30, 2008						June 30, 2007
				Weighted Avg.						Weighted Avg.						Weighted Avg.						Weighted Avg.
	Amount			Interest Rate			Amount			Interest Rate			Amount			Interest Rate			Amount			Interest Rate
Beginning balance	$	109,094			6.994	%	$	128,797			7.134	%	$	114,543			7.000	%	$	129,617			7.134	%
Debt extinguished		(2,713	)		7.000	%		(12,083	)		8.421	%		(7,463	)		7.080	%		(12,083	)		8.421	%
Principal payments		(471	)		6.973	%		(779	)		7.147	%		(1,170	)		6.974	%		(1,599	)		7.183	%
Ending balance	$	105,910			6.994	%	$	115,935			6.999	%	$	105,910			6.994	%	$	115,935			6.999	%
Monthly averages	$	108,800			6.994	%	$	125,376			7.102	%	$	110,483			6.996	%	$	127,077			7.116	%

     Depreciation and amortization increased primarily as a result of additional investments in properties owned directly by us. See the discussion of investing activities in “Liquidity and Capital Resources” above for additional details. To the extent that we acquire or dispose of additional properties in the future, our provision for depreciation and amortization will change accordingly.

     At June 30, 2008, we had ten assisted living facilities and one skilled nursing facility that satisfied the requirements of Statement No. 144 for held for sale treatment. We did not recognize any impairment losses on these assets as the fair value less estimated costs to sell exceeded our carrying values. During the six months ended June 30, 2008, we sold 19 assisted living

30

facilities, two independent living facilities, two skilled nursing facilities and one parcel of land with a carrying value of $124,536,000 for a gain of $118,194,000 and a deferred gain of $3,708,000. These properties generated $5,277,000 of income after deducting depreciation and interest expense from rental revenue for the six months ended June 30, 2008. All properties sold subsequent to January 1, 2005 and held for sale at June 30, 2008 generated $6,197,000 of income after deducting depreciation and interest expense from rental revenue for the six months ended June 30, 2007. Please refer to Note 5 to our unaudited consolidated financial statements for further discussion.

     During the three months ended December 31, 2007, we recognized $3,900,000 of additional other income related to the payoff of a warrant equity investment. During the six months ended June 30, 2008, we determined that $1,325,000 of income taxes were due in connection with that investment gain.

     Medical Office Buildings

     The following is a summary of our results of operations for the medical office buildings segment (dollars in thousands):

	Three Months Ended						Change						Six Months Ended						Change
	June 30, 2008			June 30, 2007			$			%			June 30, 2008			June 30, 2007			$			%
Revenues:
Rental income	$	33,003		$	26,181		$	6,822			26	%	$	66,236		$	49,861		$	16,375			33	%
Other income		237			0			237			n/a			447			0			447			n/a
		33,240			26,181			7,059			27	%		66,683			49,861			16,822			34	%
Expenses:
Interest expense		5,314			5,568			(254	)		-5	%		10,880			9,874			1,006			10	%
Property operating expenses		11,375			8,657			2,718			31	%		22,742			15,825			6,917			44	%
Depreciation and amortization		13,211			9,711			3,500			36	%		26,375			18,529			7,846			42	%
Loan expense		79			81			(2	)		-2	%		176			157			19			12	%
Gain on extinguishment of debt		0			0			0			n/a			(1,286	)		0			(1,286	)		n/a
		29,979			24,017			5,962			25	%		58,887			44,385			14,502			33	%
Income from continuing operations before income taxes and minority interests		3,261			2,164			1,097			51	%		7,796			5,476			2,320			42	%
Income tax (expense) benefit		(13	)		12			(25	)		n/a			(45	)		12			(57	)		n/a
Income from continuing operations before minority interests		3,248			2,176			1,072			49	%		7,751			5,488			2,263			41	%
Minority interests		(65	)		(161	)		96			-60	%		(127	)		(286	)		159			-56	%
Net income	$	3,183		$	2,015		$	1,168			58	%	$	7,624		$	5,202		$	2,422			47	%

     The increase in rental income is primarily attributable to the acquisitions of medical office buildings from which we receive rent. See the discussion of investing activities in “Liquidity and Capital Resources” above for further information. Certain of our leases contain annual rental escalators that are contingent upon changes in the Consumer Price Index. These escalators are not fixed, so no straight-line rent is recorded; however, rental income is recorded based on the contractual cash rental payments due for the period. If the Consumer Price Index does not increase, a portion of our revenues may not continue to increase. Sales of real property would offset revenue increases and, to the extent that they exceed new acquisitions, could result in decreased revenues. Our leases could renew above or below current rent rates, resulting in an increase or decrease in rental income. The increase in other income is attributable to third party management fee income.

     Interest expense for the six months ended June 30, 2008 represents $10,880,000 of secured debt interest expense. Interest expense for the six months ended June 30, 2007 represents $8,093,000 of secured debt interest expense plus $1,781,000 of interest expense related to the subsidiary trust liability. The change in secured debt interest expense is primarily due to the net effect and timing of assumptions, extinguishments and principal amortizations. During the six months ended June 30, 2008, we extinguished three medical office building secured debt loans and recognized extinguishment gains of $1,286,000. The following is a summary of our medical office building secured debt principal activity (dollars in thousands):

31

	Three Months Ended						Three Months Ended						Six Months Ended						Six Months Ended
	June 30, 2008						June 30, 2007						June 30, 2008						June 30, 2007
				Weighted Avg.						Weighted Avg.						Weighted Avg.						Weighted Avg.
	Amount			Interest Rate			Amount			Interest Rate			Amount			Interest Rate			Amount			Interest Rate
Beginning balance	$	370,103			5.777	%	$	247,709			5.939	%	$	392,430			5.854	%	$	248,783			5.939	%
Debt assumed								146,335			5.824	%								146,335			5.824	%
Debt extinguished		(8,306	)		5.000	%		(8,423	)		6.742	%		(29,239	)		6.600	%		(8,423	)		6.742	%
Principal payments		(1,346	)		5.731	%		(1,120	)		5.923	%		(2,740	)		5.729	%		(2,195	)		5.943	%
Ending balance	$	360,451			5.795	%	$	384,501			5.877	%	$	360,451			5.795	%	$	384,500			5.877	%
Monthly averages	$	363,202			5.790	%	$	318,231			5.907	%	$	372,542			5.808	%	$	288,325			5.919	%

     Additionally, at June 30, 2007, we had $51,000,000 of trust preferred liability principal outstanding with a fixed annual interest rate of 7.22%. On November 6, 2007, we purchased all $50,000,000 of the outstanding trust preferred securities at par for the purpose of unwinding this financing arrangement and extinguishing the liability of the operating partnership to the subsidiary trust. For further information, please refer to Note 8 included in our Annual Report on Form 10-K for the year ended December 31, 2007.

     The increase in property operating expenses is primarily attributable to the acquisition of new medical office buildings for which we incur certain property operating expenses.

     Depreciation and amortization increased primarily as a result of additional investments in properties owned directly by us. See the discussion of investing activities in “Liquidity and Capital Resources” above for additional details. To the extent that we acquire or dispose of additional properties in the future, our provision for depreciation and amortization will change accordingly.

     Income tax expense is related to third party management fee income.

     Minority interests primarily relate to certain joint venture properties acquired in connection with the Windrose merger in December 2006.

     Non-Segment/Corporate

     The following is a summary of our results of operations for the non-segment/corporate activities (dollars in thousands):

	Three Months Ended						Change						Six Months Ended						Change
	June 30, 2008			June 30, 2007			$			%			June 30, 2008			June 30, 2007			$			%
Revenues:
Other income	$	115		$	332		$	(217	)		-65	%	$	325		$	582		$	(257	)		-44	%
		115			332			(217	)		-65	%		325			582			(257	)		-44	%
Expenses:
Interest expense		26,210			25,744			466			2	%		53,016			51,128			1,888			4	%
General and administrative		10,575			9,957			618			6	%		22,904			19,738			3,166			16	%
Loan expense		1,674			1,155			519			45	%		3,348			2,346			1,002			43	%
		38,459			36,856			1,603			4	%		79,268			73,212			6,056			8	%
Net loss from continuing operations before income taxes		(38,344	)		(36,524	)		(1,820	)		5	%		(78,943	)		(72,630	)		(6,313	)		9	%
Income tax (expense) benefit		(31	)		(236	)		205			-87	%		73			(247	)		320			n/a
Net loss		(38,375	)		(36,760	)		(1,615	)		4	%		(78,870	)		(72,877	)		(5,993	)		8	%
Preferred stock dividends		5,784			6,317			(533	)		-8	%		11,931			12,634			(703	)		-6	%
Net loss attributable to common stockholders	$	(44,159	)	$	(43,077	)	$	(1,082	)		3	%	$	(90,801	)	$	(85,511	)	$	(5,290	)		6	%

     Other income primarily represents income from non-real estate activities such as interest earned on temporary investments of cash reserves.

     The following is a summary of our non-segment/corporate interest expense (dollars in thousands):

32

	Three Months Ended						Change						Six Months Ended						Change
	June 30, 2008			June 30, 2007			$			%			June 30, 2008			June 30, 2007			$			%
Senior unsecured notes	$	26,515		$	23,671		$	2,844			12	%	$	53,703		$	47,342		$	6,361			13	%
Unsecured lines of credit		4,798			4,592			206			4	%		9,623			8,633			990			11	%
Capitalized interest		(5,063	)		(2,570	)		(2,493	)		97	%		(10,230	)		(4,896	)		(5,334	)		109	%
SWAP losses (savings)		(40	)		51			(91	)		n/a			(80	)		50			(130	)		n/a
Totals	$	26,210		$	25,744		$	466			2	%	$	53,016		$	51,129		$	1,887			4	%

     The increase in interest expense on senior unsecured notes is due to higher average borrowings offset partially by lower average interest rates. The following is a summary of our senior unsecured note principal activity (dollars in thousands):

	Three Months Ended					Three Months Ended					Six Months Ended						Six Months Ended
	June 30, 2008					June 30, 2007					June 30, 2008						June 30, 2007
	Face		Weighted Avg.			Face		Weighted Avg.			Face			Weighted Avg.			Face		Weighted Avg.
	Amount		Interest Rate			Amount		Interest Rate			Amount			Interest Rate			Amount		Interest Rate
Beginning balance	$	1,845,000		5.782	%	$	1,539,830		6.159	%	$	1,887,330			5.823	%	$	1,539,830		6.159	%
Principal payments												(42,330	)		7.625	%
Ending balance	$	1,845,000		5.782	%	$	1,539,830		6.159	%	$	1,845,000			5.782	%	$	1,539,830		6.159	%

     The change in interest expense on the unsecured line of credit arrangement is due primarily to the net effect and timing of draws, paydowns and variable interest rate changes. The following is a summary of our unsecured line of credit arrangement (dollars in thousands):

	Three Months Ended June 30,						Six Months Ended June 30,
	2008			2007			2008			2007
Balance outstanding at quarter end	$	744,000		$	364,400		$	744,000		$	364,400
Maximum amount outstanding at any month end	$	744,000		$	364,400		$	744,000		$	381,000
Average amount outstanding (total of daily principal balances divided by days in period)	$	542,766		$	270,891		$	474,726		$	257,346
Weighted average interest rate (actual interest expense divided by average borrowings outstanding)		3.54	%		6.78	%		4.05	%		6.71	%

     We capitalize certain interest costs associated with funds used to finance the construction of properties owned directly by us. The amount capitalized is based upon the borrowings outstanding during the construction period using the rate of interest that approximates our cost of financing. Our interest expense is reduced by the amount capitalized.

     Please see Note 10 to our unaudited consolidated financial statements for a discussion of our interest rate swap agreements and their impact on interest expense.

     General and administrative expenses as a percentage of revenues (including revenues from discontinued operations) for the three and six months ended June 30, 2008 were 7.51% and 8.27%, respectively, as compared with 8.29% and 8.47% for the same periods in 2007. The increase from 2007 is primarily related to costs associated with our initiatives to attract and retain appropriate personnel to achieve our business objectives.

     Loan expense represents the amortization of deferred loan costs incurred in connection with the issuance and amendments of debt. The change in loan expense is primarily due to costs associated with the issuance of $400,000,000 of senior unsecured convertible notes in July 2007 and costs associated with the amendment of our unsecured line of credit arrangement in August 2007.

     The change in preferred dividends is primarily attributable to preferred stock conversions. The following is a summary of our preferred stock activity (dollars in thousands):

33

	Three Months Ended						Three Months Ended					Six Months Ended						Six Months Ended
	June 30, 2008						June 30, 2007					June 30, 2008						June 30, 2007
				Weighted Avg.					Weighted Avg.						Weighted Avg.					Weighted Avg.
	Shares			Dividend Rate			Shares		Dividend Rate			Shares			Dividend Rate			Shares		Dividend Rate
Beginning balance		12,799,889			7.677	%		13,174,989		7.672	%		12,879,189			7.676	%		13,174,989		7.672	%
Shares converted		(751,050	)		7.500	%							(830,350	)		7.500	%
Ending balance		12,048,839			7.688	%		13,174,989		7.672	%		12,048,839			7.688	%		13,174,989		7.672	%
Monthly averages		12,242,227			7.685	%		13,174,989		7.672	%		12,495,896			7.681	%		13,174,989		7.672	%

Non-GAAP Financial Measures

          We believe that net income, as defined by U.S. GAAP, is the most appropriate earnings measurement. However, we consider FFO to be a useful supplemental measure of our operating performance. Historical cost accounting for real estate assets in accordance with U.S. GAAP implicitly assumes that the value of real estate assets diminishes predictably over time as evidenced by the provision for depreciation. However, since real estate values have historically risen or fallen with market conditions, many industry investors and analysts have considered presentations of operating results for real estate companies that use historical cost accounting to be insufficient. In response, the National Association of Real Estate Investment Trusts (“NAREIT”) created FFO as a supplemental measure of operating performance for REITs that excludes historical cost depreciation from net income. FFO, as defined by NAREIT, means net income, computed in accordance with U.S. GAAP, excluding gains (or losses) from sales of real estate, plus depreciation and amortization, and after adjustments for unconsolidated partnerships and joint ventures.

          Net operating income (“NOI”) is used to evaluate the operating performance of our properties. We define NOI as total revenues, including tenant reimbursements, less property level operating expenses, which exclude depreciation and amortization, general and administrative expenses, impairments and interest expense. We believe NOI provides investors relevant and useful information because it measures the operating performance of our properties at the property level on an unleveraged basis. We use NOI to make decisions about resource allocations and to assess the property level performance of our properties.

          EBITDA stands for earnings before interest, taxes, depreciation and amortization. We believe that EBITDA, along with net income and cash flow provided from operating activities, is an important supplemental measure because it provides additional information to assess and evaluate the performance of our operations. We primarily utilize EBITDA to measure our interest coverage ratio, which represents EBITDA divided by total interest, and our fixed charge coverage ratio, which represents EBITDA divided by fixed charges. Fixed charges include total interest, secured debt principal amortization and preferred dividends.

          A covenant in our line of credit arrangement contains a financial ratio based on a definition of EBITDA that is specific to that agreement. Failure to satisfy this covenant could result in an event of default that could have a material adverse impact on our cost and availability of capital, which could in turn have a material adverse impact on our consolidated results of operations, liquidity and/or financial condition. Due to the materiality of this debt agreement and the financial covenant, we have disclosed Adjusted EBITDA, which represents EBITDA as defined above and adjusted for stock-based compensation expense, provision for loan losses and gain/loss on extinguishment of debt. We use Adjusted EBITDA to measure our adjusted fixed charge coverage ratio, which represents Adjusted EBITDA divided by fixed charges on a trailing twelve months basis. Fixed charges include total interest (excluding capitalized interest), secured debt principal amortization and preferred dividends. Our covenant requires an adjusted fixed charge ratio of at least 1.75 times.

          In April 2002, the Financial Accounting Standards Board issued Statement No. 145 that requires gains and losses on extinguishment of debt to be classified as income or loss from continuing operations rather than as extraordinary items as previously required under Statement No. 4. We adopted the standard effective January 1, 2003. We have properly reflected the $1,326,000, or $0.02 per diluted share, of gains on extinguishment of debt for the quarter ended March 31, 2008 and the $1,081,000, or $0.01 per diluted share, of gains on extinguishment of debt for the quarter ended December 31, 2007. These amounts have not been added back for the calculations of FFO or EBITDA.

          During the quarter ended June 30, 2007, we recorded $1,750,000 ($0.02 per diluted share) of one-time acquisition finders’ fees paid to former Windrose management in connection with the closing of the Rendina/Paramount transaction. These fees relate to services rendered prior to the consummation of the Windrose merger in December 2006. Due to the recipients’ current employment status with the company, the fees were expensed as compensation rather than included in the purchase price of the acquisition, as is typical with such fees. These fees have not been added back for the calculations of FFO or EBITDA.

          During the quarter ended March 31, 2008, we recorded $1,325,000 ($0.02 per diluted share) of non-recurring income tax expense. These taxes have not been added back for the calculations of FFO.

34

          Other than Adjusted EBITDA, our supplemental measures are financial measures that are widely used by investors, equity and debt analysts and rating agencies in the valuation, comparison, rating and investment recommendations of companies. Management uses these financial measures to facilitate internal and external comparisons to our historical operating results and in making operating decisions. Additionally, these measures are utilized by the Board of Directors to evaluate management. Adjusted EBITDA is used solely to determine our compliance with a financial covenant of our line of credit arrangement and is not being presented for use by investors for any other purpose. None of our supplemental measures represent net income or cash flow provided from operating activities as determined in accordance with U.S. GAAP and should not be considered as alternative measures of profitability or liquidity. Finally, the supplemental measures, as defined by us, may not be comparable to similarly entitled items reported by other real estate investment trusts or other companies.

          The table below reflects the reconciliation of FFO to net income available to common stockholders, the most directly comparable U.S. GAAP measure, for the periods presented. The provisions for depreciation and amortization include provisions for depreciation and amortization from discontinued operations. Amounts are in thousands except for per share data.

	Three Months Ended
	March 31,			June 30,			September 30,			December 31,			March 31,			June 30,
	2007			2007			2007			2007			2008			2008
FFO Reconciliation:
Net income available to common stockholders	$	23,356		$	25,620		$	24,529		$	42,768		$	30,452		$	156,613
Depreciation and amortization		33,860			35,547			40,137			40,081			39,574			39,630
Loss (gain) on sales of properties		(977	)		(1,033	)		(766	)		(11,662	)		(26	)		(118,168	)
Minority interests		(32	)		(155	)		(70	)		(88	)		(87	)		(87	)
Funds from operations	$	56,207		$	59,979		$	63,830		$	71,099		$	69,913		$	77,988
Average common shares outstanding:
Basic		73,224			79,060			80,710			82,346			86,100			89,294
Diluted		73,791			79,546			81,163			82,784			86,610			89,853
Per share data:
Net income available to common stockholders
Basic	$	0.32		$	0.32		$	0.30		$	0.52		$	0.35		$	1.75
Diluted		0.32			0.32			0.30			0.52			0.35			1.74
Funds from operations
Basic	$	0.77		$	0.76		$	0.79		$	0.86		$	0.81		$	0.87
Diluted		0.76			0.75			0.79			0.86			0.81			0.87

	Six Months Ended
	June 30,			June 30,
	2007			2008
FFO Reconciliation:
Net income available to common stockholders	$	48,976		$	187,065
Depreciation and amortization		69,408			79,203
Loss (gain) on sales of properties		(2,010	)		(118,194	)
Minority interests		(187	)		(174	)
Funds from operations	$	116,187		$	147,900
Average common shares outstanding:
Basic		76,159			87,698
Diluted		76,714			88,223
Per share data:
Net income available to common stockholders
Basic	$	0.64		$	2.13
Diluted		0.64			2.12
Funds from operations
Basic	$	1.53		$	1.69
Diluted		1.51			1.68

35

          The table below reflects the reconciliation of NOI for the periods presented. All amounts include amounts from discontinued operations, if applicable. Amounts are in thousands.

	Three Months Ended
	March 31,		June 30,		September 30,		December 31,		March 31,		June 30,
	2007		2007		2007		2007		2008		2008
NOI Reconciliation:
Total revenues:
Investment properties:
Rental income:
Independent living/CCRCs	$	9,387	$	9,477	$	11,765	$	12,443	$	13,414	$	14,881
Assisted living facilities		25,750		25,345		28,734		28,646		30,228		31,071
Skilled nursing facilities		41,011		44,713		40,970		41,025		40,100		40,260
Specialty care facilities		6,340		6,581		6,485		7,012		8,191		10,595
Sub-total rental income		82,488		86,116		87,954		89,126		91,933		96,807
Interest income		5,149		6,576		5,947		8,151		9,092		9,175
Other income		1,343		812		637		5,218		1,296		1,533
Total investment property income		88,980		93,504		94,538		102,495		102,321		107,515
Medical office buildings:
Rental income		23,680		26,181		30,876		30,877		33,233		33,003
Other income		0		0		0		497		210		237
Total medical office building income		23,680		26,181		30,876		31,374		33,443		33,240
Non-segment/corporate other income		249		332		562		384		210		115
Total revenues		112,909		120,017		125,976		134,253		135,974		140,870
Property operating expenses:
Investment properties		0		0		0		0		0		0
Medical office buildings		7,168		8,657		10,426		11,224		11,367		11,375
Non-segment/corporate		0		0		0		0		0		0
Total property operating expenses		7,168		8,657		10,426		11,224		11,367		11,375
Net operating income:
Investment properties		88,980		93,504		94,538		102,495		102,321		107,515
Medical office buildings		16,512		17,524		20,450		20,150		22,076		21,865
Non-segment/corporate		249		332		562		384		210		115
Net operating income	$	105,741	$	111,360	$	115,550	$	123,029	$	124,607	$	129,495

	Six Months Ended
	June 30,		June 30,
	2007		2008
NOI Reconciliation:
Total revenues:
Investment properties:
Rental income:
Independent living/CCRCs	$	18,864	$	28,295
Assisted living facilities		51,095		61,299
Skilled nursing facilities		85,724		80,360
Specialty care facilities		12,920		18,786
Sub-total rental income		168,603		188,740
Interest income		11,725		18,267
Other income		2,155		2,829
Total investment property income		182,483		209,836
Medical office buildings:
Rental income		49,861		66,236
Other income		0		447
Total medical office building income		49,861		66,683
Non-segment/corporate other income		582		325
Total revenues		232,926		276,844
Property operating expenses:
Investment properties		0		0
Medical office buildings		15,825		22,742
Non-segment/corporate		0		0
Total property operating expenses		15,825		22,742
Net operating income:
Investment properties		182,483		209,836
Medical office buildings		34,036		43,941
Non-segment/corporate		582		325
Net operating income	$	217,101	$	254,102

36

          The table below reflects the reconciliation of EBITDA to net income, the most directly comparable U.S. GAAP measure, for the periods presented. Interest expense and the provisions for depreciation and amortization include discontinued operations. Amortization represents the amortization of deferred loan expenses. Dollars are in thousands.

	Three Months Ended
	March 31,			June 30,			September 30,			December 31,			March 31,			June 30,
	2007			2007			2007			2007			2008			2008
EBITDA Reconciliation:
Net income	$	29,673		$	31,937		$	30,846		$	48,947		$	36,599		$	162,397
Interest expense		31,999			33,624			35,082			35,593			34,345			33,199
Income tax expense (benefit)		11			(69	)		(23	)		269			1,279			44
Depreciation and amortization		33,860			35,547			40,137			40,081			39,574			39,630
Amortization of deferred loan expenses		1,267			1,236			1,504			1,971			1,772			1,753
EBITDA	$	96,810		$	102,275		$	107,546		$	126,861		$	113,569		$	237,023
Interest Coverage Ratio:
Interest expense	$	31,999		$	33,624		$	35,082		$	35,593		$	34,345		$	33,199
Capitalized interest		2,327			2,570			3,162			4,468			5,167			5,063
Total interest		34,326			36,194			38,244			40,061			39,512			38,262
EBITDA	$	96,810		$	102,275		$	107,546		$	126,861		$	113,569		$	237,023
Interest coverage ratio		2.82	x		2.83	x		2.81	x		3.17	x		2.87	x		6.19	x
Fixed Charge Coverage Ratio:
Total interest	$	34,326		$	36,194		$	38,244		$	40,061		$	39,512		$	38,262
Secured debt principal amortization		1,894			1,900			2,022			2,147			2,093			1,817
Preferred dividends		6,317			6,317			6,317			6,179			6,147			5,784
Total fixed charges		42,537			44,411			46,583			48,387			47,752			45,863
EBITDA	$	96,810		$	102,275		$	107,546		$	126,861		$	113,569		$	237,023
Fixed charge coverage ratio		2.28	x		2.30	x		2.31	x		2.62	x		2.38	x		5.17	x

	Six Months Ended
	June 30,			June 30,
	2007			2008
EBITDA Reconciliation:
Net income	$	61,610		$	198,996
Interest expense		65,624			67,545
Tax expense (benefit)		(58	)		1,323
Depreciation and amortization		69,408			79,203
Amortization of deferred loan expenses		2,503			3,524
EBITDA	$	199,087		$	350,591
Interest Coverage Ratio:
Interest expense	$	65,624		$	67,545
Capitalized interest		4,896			10,230
Total interest		70,520			77,775
EBITDA	$	199,087		$	350,591
Interest coverage ratio		2.82	x		4.51	x
Fixed Charge Coverage Ratio:
Total interest	$	70,520		$	77,775
Secured debt principal amortization		3,794			3,910
Preferred dividends		12,634			11,931
Total fixed charges		86,948			93,616
EBITDA	$	199,087		$	350,591
Fixed charge coverage ratio		2.29	x		3.74	x

37

          The table below reflects the reconciliation of Adjusted EBITDA to net income, the most directly comparable U.S. GAAP measure, for the periods presented. Interest expense and the provisions for depreciation and amortization include discontinued operations. Amortization represents the amortization of deferred loan expenses. Dollars are in thousands.

	Twelve Months Ended
	March 31,			June 30,			September 30,			December 31,			March 31,			June 30,
	2007			2007			2007			2007			2008			2008
Adjusted EBITDA Reconciliation:
Net income	$	107,445		$	111,381		$	115,414		$	141,402		$	148,329		$	278,789
Interest expense		104,595			115,132			125,940			136,302			138,644			138,219
Income tax expense (benefit)		93			12			(81	)		188			1,456			1,569
Depreciation and amortization		108,162			119,578			135,189			149,626			155,339			159,422
Amortization of deferred loan expenses		3,812			4,341			5,063			5,977			6,483			7,000
Stock-based compensation expense		7,643			8,081			8,543			7,050			7,723			7,853
Provision for loan losses		750			500			250			0			0			0
Loss (gain) on extinguishment of debt		0			0			0			(1,081	)		(2,407	)		(2,407	)
Adjusted EBITDA	$	332,500		$	359,025		$	390,318		$	439,464		$	455,567		$	590,445
Adjusted Fixed Charge Coverage Ratio:
Interest expense	$	104,595		$	115,132		$	125,940		$	136,302		$	138,644		$	138,219
Capitalized interest		6,596			8,257			10,035			12,526			15,367			17,860
Secured debt principal amortization		4,284			5,416			6,665			7,961			8,162			8,079
Preferred dividends		22,447			23,431			24,415			25,130			24,960			24,427
Total fixed charges		137,922			152,236			167,055			181,919			187,133			188,585
Adjusted EBITDA	$	332,500		$	359,025		$	390,318		$	439,464		$	455,567		$	590,445
Adjusted fixed charge coverage ratio		2.41	x		2.36	x		2.34	x		2.42	x		2.43	x		3.13	x

38

Critical Accounting Policies

          Our consolidated financial statements are prepared in accordance with U.S. GAAP, which requires us to make estimates and assumptions. Management considers an accounting estimate or assumption critical if:

• the nature of the estimates or assumptions is material due to the levels of subjectivity and judgment necessary to account for highly uncertain matters or the susceptibility of such matters to change; and

• the impact of the estimates and assumptions on financial condition or operating performance is material.

          Management has discussed the development and selection of its critical accounting policies with the Audit Committee of the Board of Directors and the Audit Committee has reviewed the disclosure presented below relating to them. Management believes the current assumptions and other considerations used to estimate amounts reflected in our consolidated financial statements are appropriate and are not reasonably likely to change in the future. However, since these estimates require assumptions to be made that were uncertain at the time the estimate was made, they bear the risk of change. If actual experience differs from the assumptions and other considerations used in estimating amounts reflected in our consolidated financial statements, the resulting changes could have a material adverse effect on our consolidated results of operations, liquidity and/or financial condition. Please refer to our Annual Report on Form 10-K for the year ended December 31, 2007 for further information regarding significant accounting policies that impact us. There have been no material changes to these policies in 2008. See Note 2 to our consolidated financial statements for the impact of new accounting pronouncements.

          The following table presents information about our critical accounting policies, as well as the material assumptions used to develop each estimate:

Nature of Critical	Assumptions/Approach
Accounting Estimate	Used
Allowance for Loan Losses
We maintain an allowance for loan losses in accordance with Statement of Financial Accounting Standards No. 114, Accounting by Creditors for Impairment of a Loan, as amended, and SEC Staff Accounting Bulletin No. 102, Selected Loan Loss Allowance Methodology and Documentation Issues. The allowance for loan losses is maintained at a level believed adequate to absorb potential losses in our loans receivable. The determination of the allowance is based on a quarterly evaluation of all outstanding loans. If this evaluation indicates that there is a greater risk of loan charge-offs, additional allowances or placement on non-accrual status may be required. A loan is impaired when, based on current information and events, it is probable that we will be unable to collect all amounts due as scheduled according to the contractual terms of the original loan agreement. Consistent with this definition, all loans on non-accrual are deemed impaired. To the extent circumstances improve and the risk of collectibility is diminished, we will return these loans to full accrual status.	The determination of the allowance is based on a quarterly evaluation of all outstanding loans, including general economic conditions and estimated collectibility of loan payments and principal. We evaluate the collectibility of our loans receivable based on a combination of factors, including, but not limited to, delinquency status, historical loan charge-offs, financial strength of the borrower and guarantors and value of the underlying property. As a result of our quarterly evaluation, we concluded that the allowance for loan losses at December 31, 2007 remained appropriate as of June 30, 2008, resulting in an allowance for loan losses of $7,406,000 relating to loans with outstanding balances of $117,894,000. Also at June 30, 2008, we had loans with outstanding balances of $21,609,000 on non-accrual status.

39

Nature of Critical	Assumptions/Approach
Accounting Estimate	Used
Business Combinations
Substantially all of the properties owned by us are leased under operating leases and are recorded at cost. The cost of our real property is allocated to land, buildings, improvements and intangibles in accordance with Statement of Financial Accounting Standards No. 141, Business Combinations.	We compute depreciation and amortization on our properties using the straight-line method based on their estimated useful lives which range from 15 to 40 years for buildings and five to 15 years for improvements. Lives for intangibles are based on the remaining term of the underlying leases.
	For the six months ended June 30, 2008, we recorded $64,229,000, $8,194,000 and $6,780,000 as provisions for depreciation and amortization relating to buildings, improvements and intangibles, respectively, including amounts reclassified as discontinued operations. The average useful life of our buildings, improvements and intangibles was 32.6 years, 13.1 years and 6.0 years, respectively, for the six months ended June 30, 2008.
Impairment of Long-Lived Assets
We review our long-lived assets for potential impairment in accordance with Statement of Financial Accounting Standards No. 144, Accounting for the Impairment and Disposal of Long-Lived Assets. An impairment charge must be recognized when the carrying value of a long-lived asset is not recoverable. The carrying value is not recoverable if it exceeds the sum of the undiscounted cash flows expected to result from the use and eventual disposition of the asset. If it is determined that a permanent impairment of a long-lived asset has occurred, the carrying value of the asset is reduced to its fair value and an impairment charge is recognized for the difference between the carrying value and the fair value.	The net book value of long-lived assets is reviewed quarterly on a property by property basis to determine if there are indicators of impairment. These indicators may include anticipated operating losses at the property level, the tenant’s inability to make rent payments, a decision to dispose of an asset before the end of its estimated useful life and changes in the market that may permanently reduce the value of the property. If indicators of impairment exist, then the undiscounted future cash flows from the most likely use of the property are compared to the current net book value. This analysis requires us to determine if indicators of impairment exist and to estimate the most likely stream of cash flows to be generated from the property during the period the property is expected to be held.
	We did not record any impairment charges for the six months ended June 30, 2008.
Fair Value of Derivative Instruments
The valuation of derivative instruments is accounted for in accordance with Statement of Financial Accounting Standards No. 133, Accounting for Derivative Instruments and Hedging Activities (“SFAS133”), as amended by Statement of Financial Accounting Standards No. 138, Accounting for Certain Derivative Instruments and Certain Hedging Activities. SFAS133, as amended, requires companies to record derivatives at fair market value on the balance sheet as assets or liabilities.	The valuation of derivative instruments requires us to make estimates and judgments that affect the fair value of the instruments. Fair values for our derivatives are estimated by utilizing pricing models that consider forward yield curves and discount rates. Such amounts and the recognition of such amounts are subject to significant estimates which may change in the future. At June 30, 2008, we participated in two forward-starting interest rate swap agreements. At June 30, 2008, the swaps were reported at their fair value of negative $8,486,000 and are included in other liabilities and accumulated other comprehensive income.

40

Nature of Critical	Assumptions/Approach
Accounting Estimate	Used
Revenue Recognition
Revenue is recorded in accordance with Statement of Financial Accounting Standards No. 13, Accounting for Leases, and SEC Staff Accounting Bulletin No. 104, Revenue Recognition in Financial Statements, as amended (“SAB104”). SAB104 requires that revenue be recognized after four basic criteria are met. These four criteria include persuasive evidence of an arrangement, the rendering of service, fixed and determinable income and reasonably assured collectibility. If the collectibility of revenue is determined incorrectly, the amount and timing of our reported revenue could be significantly affected. Interest income on loans is recognized as earned based upon the principal amount outstanding subject to an evaluation of collectibility risk. Substantially all of our operating leases contain fixed and/or contingent escalating rent structures. Leases with fixed annual rental escalators are generally recognized on a straight-line basis over the initial lease period, subject to a collectibility assessment. Rental income related to leases with contingent rental escalators is generally recorded based on the contractual cash rental payments due for the period.	We evaluate the collectibility of our revenues and related receivables on an on-going basis. We evaluate collectibility based on assumptions and other considerations including, but not limited to, the certainty of payment, payment history, the financial strength of the investment’s underlying operations as measured by cash flows and payment coverages, the value of the underlying collateral and guaranties and current economic conditions. If our evaluation indicates that collectibility is not reasonably assured, we may place an investment on non-accrual or reserve against all or a portion of current income as an offset to revenue. For the six months ended June 30, 2008, we recognized $18,267,000 of interest income and $254,976,000 of rental income, including discontinued operations. Cash receipts on leases with deferred revenue provisions were $10,898,000 as compared to gross straight-line rental income recognized of $10,370,000 for the six months ended June 30, 2008. At June 30, 2008, our straight-line receivable balance was $52,228,000, net of reserves totaling $1,152,000. Also at June 30, 2008, we had loans with outstanding balances of $21,609,000 on non-accrual status.

Forward-Looking Statements and Risk Factors

          This Quarterly Report on Form 10-Q may contain “forward-looking” statements as defined in the Private Securities Litigation Reform Act of 1995. These forward-looking statements concern and are based upon, among other things, the possible expansion of the company’s portfolio; the sale of properties; the performance of its operators and properties; its occupancy rates; its ability to acquire or develop properties; its ability to manage properties; its ability to enter into agreements with viable new tenants for vacant space or for properties that the company takes back from financially troubled tenants, if any; its ability to make distributions; its policies and plans regarding investments, financings and other matters; its tax status as a real estate investment trust; its ability to appropriately balance the use of debt and equity; its ability to access capital markets or other sources of funds; its critical accounting policies; and its ability to meet its earnings guidance. When the company uses words such as “may,” “will,” “intend,” “should,” “believe,” “expect,” “anticipate,” “project,” “estimate” or similar expressions, it is making forward-looking statements. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties. The company’s expected results may not be achieved, and actual results may differ materially from expectations. This may be a result of various factors, including, but not limited to: the status of the economy; the status of capital markets, including availability and cost of capital; issues facing the health care industry, including compliance with, and changes to, regulations and payment policies; and operators’/tenants’ difficulty in cost-effectively obtaining and maintaining adequate liability and other insurance; changes in financing terms; competition within the health care and senior housing industries; negative developments in the operating results or financial condition of operators/tenants, including, but not limited to, their ability to pay rent and repay loans; the company’s ability to transition or sell facilities with profitable results; the failure to make new investments as and when anticipated; the failure of closings to occur as and when anticipated; acts of God affecting the company’s properties; the company’s ability to re-lease space at similar rates as vacancies occur; the company’s ability to timely reinvest sale proceeds at similar rates to assets sold; operator/tenant bankruptcies or insolvencies; government regulations affecting Medicare and Medicaid reimbursement rates and operational requirements; liability or contract claims by or against operators/tenants; unanticipated difficulties and/or expenditures relating to future acquisitions; environmental laws affecting the company’s properties; changes in rules or practices governing the company’s financial reporting; and legal and operational matters, including real estate investment trust qualification and key management personnel recruitment and retention. Other important factors are identified in the company’s Annual Report on Form 10-K for the year ended December 31, 2007, including factors identified under the headings “Business,” “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations.” Finally, the company assumes no obligation to update or revise any forward-looking statements or to update the reasons why actual results could differ from those projected in any forward-looking statements.

41

Item 3. Quantitative and Qualitative Disclosures about Market Risk

          We are exposed to various market risks, including the potential loss arising from adverse changes in interest rates. We seek to mitigate the effects of fluctuations in interest rates by matching the terms of new investments with new long-term fixed rate borrowings to the extent possible. We may or may not elect to use financial derivative instruments to hedge interest rate exposure. These decisions are principally based on our policy to match our variable rate investments with comparable borrowings, but are also based on the general trend in interest rates at the applicable dates and our perception of the future volatility of interest rates. This section is presented to provide a discussion of the risks associated with potential fluctuations in interest rates.

          We historically borrow on our unsecured line of credit arrangement to acquire, construct or make loans relating to health care and senior housing properties. Then, as market conditions dictate, we will issue equity or long-term fixed rate debt to repay the borrowings under the unsecured line of credit arrangement.

          A change in interest rates will not affect the interest expense associated with our fixed rate debt. Interest rate changes, however, will affect the fair value of our fixed rate debt. Changes in the interest rate environment upon maturity of this fixed rate debt could have an effect on our future cash flows and earnings, depending on whether the debt is replaced with other fixed rate debt, variable rate debt or equity or repaid by the sale of assets. To illustrate the impact of changes in the interest rate markets, we performed a sensitivity analysis on our fixed rate debt instruments whereby we modeled the change in net present values arising from a hypothetical 1% increase in interest rates to determine the instruments’ change in fair value. The following table summarizes the analysis performed as of the dates indicated (in thousands):

	June 30, 2008					December 31, 2007
	Principal		Change in			Principal		Change in
	balance		fair value			balance		fair value
Senior unsecured notes	$	1,845,000	$	(142,191	)	$	1,887,330	$	(96,726	)
Secured debt		466,361		(21,852	)		492,741		(24,530	)
Totals	$	2,311,361	$	(164,043	)	$	2,380,071	$	(121,256	)

          On September 12, 2007, we entered into two forward-starting interest rate swaps (the “September 2007 Swaps”) for a total notional amount of $250,000,000 to hedge 10 years of interest payments associated with a long-term borrowing that is expected to occur in 2008. The September 2007 Swaps each have an effective date of September 12, 2008 and a maturity date of September 12, 2018. We expect to settle the September 2007 Swaps when the forecasted debt is priced. The September 2007 Swaps have the economic effect of fixing $250,000,000 of our future debt at 4.469% plus a credit spread for 10 years. The September 2007 Swaps have been designated as cash flow hedges and we expect the September 2007 Swaps to be highly effective at offsetting changes in cash flows of interest payments on $250,000,000 of our future debt due to changes in the LIBOR swap rate. Therefore, effective changes in the fair value of the September 2007 Swaps will be recorded in accumulated other comprehensive income (“AOCI”) and reclassified to interest expense when the hedged forecasted transactions affect earnings (as interest payments are made on the expected debt issuance). The ineffective portion of the changes in fair value will be recorded directly in earnings. At June 30, 2008, the September 2007 Swaps were reported at their fair value of negative $8,486,000 and are included in other liabilities and AOCI as there was no hedge ineffectiveness. A 1% increase in interest rates would result in an increase in fair value of our September 2007 Swaps by approximately $10,890,000 at June 30, 2008. At December 31, 2007, the September 2007 Swaps were reported at their fair value of negative $7,990,000 and were included in other liabilities and AOCI. A 1% increase in interest rates would result in an increase in fair value of our September 2007 Swaps by approximately $10,871,000 at December 31, 2007.

          Our variable rate debt, including our unsecured line of credit arrangement, is reflected at fair value. At June 30, 2008, we had $744,000,000 outstanding related to our variable rate debt and assuming no changes in outstanding balances, a 1% increase in interest rates would result in increased annual interest expense of $7,440,000. At December 31, 2007, we had $321,232,000 outstanding related to our variable rate debt and assuming no changes in outstanding balances, a 1% increase in interest rates would have resulted in increased annual interest expense of $3,212,000.

          We are subject to risks associated with debt financing, including the risk that existing indebtedness may not be refinanced or that the terms of refinancing may not be as favorable as the terms of current indebtedness. The majority of our borrowings were completed under indentures or contractual agreements that limit the amount of indebtedness we may incur. Accordingly, in the event that we are unable to raise additional equity or borrow money because of these limitations, our ability to acquire additional properties may be limited.

42

Item 4. Controls and Procedures

          Our management, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on that evaluation, the Chief Executive Officer and Chief Financial Officer have concluded that our disclosure controls and procedures are effective in providing reasonable assurance that information required to be disclosed by us in the reports we file with or submit to the Securities and Exchange Commission (“SEC”) under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. No changes in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) occurred during the fiscal quarter covered by this Quarterly Report on Form 10-Q that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

PART II. OTHER INFORMATION

Item 1A. Risk Factors

          Except as provided in “Item 2 — Management’s Discussion and Analysis of Financial Condition and Results of Operations — Forward Looking Statements and Risk Factors,” there have been no material changes from the risk factors identified under the heading “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2007.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

ISSUER PURCHASES OF EQUITY SECURITIES

					Total Number	Maximum Number
					of Shares Purchased	of Shares that May
	Total Number				as Part of Publicly	Yet Be Purchased
	of Shares		Average Price		Announced	Under the Plans or
Period	Purchased (1)		Paid Per Share		Plans or Programs (2)	Programs
April 1, 2008 through April 30, 2008
May 1, 2008 through May 31, 2008		117	$	49.96
June 1, 2008 through June 30, 2008
Totals		117	$	49.96

(1)	During the three months ended June 30, 2008, the only securities purchased by the Company were shares of common stock held by employees who tendered owned shares to satisfy the tax withholding on the lapse of certain restrictions on restricted stock.
(2)	No shares were purchased as part of publicly announced plans or programs.

Item 4. Submission of Matters to a Vote of Security Holders

          Our annual meeting of stockholders was duly called and held on May 1, 2008 in Toledo, Ohio. Proxies for the meeting were solicited on behalf of the Board of Directors pursuant to Regulation 14A of the General Rules and Regulations of the SEC. There was no solicitation in opposition to the Board’s nominees for election as directors as listed in the Proxy Statement, and all such nominees were elected.

          Votes were cast at the meeting upon the proposals described in the Proxy Statement for the meeting (filed with the SEC pursuant to Regulation 14A and incorporated herein by reference) as follows:

          Proposal #1 — Election of three directors for a term of three years:

Nominee	For		Withheld
William C. Ballard, Jr.		76,895,047		820,242
Peter J. Grua		76,873,921		841,368
R. Scott Trumbull		77,050,549		664,740

43

          Proposal #2 — Ratification of the appointment of Ernst & Young LLP as independent registered public accounting firm for the fiscal year 2008:

For	77,158,162
Against	361,537
Abstain	195,590

Item 6. Exhibits

10.1	Stock Option Agreement (with Dividend Equivalent Rights), dated as of January 21, 2008, by and between Health Care REIT, Inc. and Frederick L. Farrar.
10.2	Stock Option Agreement (without Dividend Equivalent Rights), dated as of January 21, 2008, by and between Health Care REIT, Inc. and Frederick L. Farrar.
10.3	Restricted Stock Agreement, dated as of January 21, 2008, by and between Health Care REIT, Inc. and Frederick L. Farrar.
10.4	Amended and Restated Employment Agreement, dated as of June 18, 2008, by and between Health Care REIT, Inc. and Daniel R. Loftus.
31.1	Rule 13a-14(a)/15d-14(a) Certification of Chief Executive Officer.
31.2	Rule 13a-14(a)/15d-14(a) Certification of Chief Financial Officer.
32.1	Certification pursuant to 18 U.S.C. Section 1350 by Chief Executive Officer.
32.2	Certification pursuant to 18 U.S.C. Section 1350 by Chief Financial Officer.

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

	HEALTH CARE REIT, INC.
Date: August 6, 2008	By:	/s/ George L. Chapman
	George L. Chapman,
	Chairman and Chief Executive Officer (Principal Executive Officer)

Date: August 6, 2008	By:	/s/ Scott A. Estes
	Scott A. Estes,
	Senior Vice President and Chief Financial Officer (Principal Financial Officer)

Date: August 6, 2008	By:	/s/ Paul D. Nungester, Jr.
	Paul D. Nungester, Jr.,
	Vice President and Controller (Principal Accounting Officer)

44

EX-10.1

EXHIBIT 10.1

STOCK OPTION AGREEMENT

     THIS STOCK OPTION AGREEMENT (the “Agreement”), made this 21st day of January, 2008 between Health Care REIT, Inc., a Delaware corporation (the “Corporation”), and Frederick L. Farrar (the “Participant”).

WITNESSETH:

     WHEREAS, the Participant is an executive officer of the Corporation; and

     WHEREAS, the Corporation adopted the Health Care REIT, Inc. 2005 Long-Term Incentive Plan (the “Plan”) in order to provide non-employee directors and select officers and key employees with incentives to achieve long-term corporate objectives; and

     WHEREAS, the Compensation Committee of the Corporation’s Board of Directors decided that the Participant should be granted stock options to purchase shares of the Corporation’s common stock, $1.00 par value per share (“Common Stock”), on the terms and conditions set forth below, and in accordance with the terms of the Plan.

     NOW, THEREFORE, in consideration of the covenants and agreements herein contained and intending to be legally bound hereby, the parties hereto agree as follows:

     1. Grant of Options.

          Subject to the terms and conditions of this Agreement, the Corporation hereby grants to the Participant the right and option to purchase up to a total of 2,483 shares of the Common Stock of the Corporation, at the option price of $40.83 per share (the “Options”).

          The Options shall consist of options to purchase 0 shares of Common Stock intended to qualify as incentive stock options (“ISOs”) within the meaning of Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”), and options to purchase 2,483 shares of Common Stock not intended to qualify as ISOs (“Nonstatutory Options”).

     2. Period of Exercise.

          The Options shall become exercisable by the Participant in two installments. Subject to the accelerated vesting provided for in Sections 9, 10 and 11 below, at any time during the term of the Options, the maximum number of shares of Common Stock the Participant may purchase by exercising Nonstatutory Options, and the maximum number which the Participant may purchase by exercising ISOs, shall be limited as specified in the following schedule:

	MAXIMUM NUMBER OF
	SHARES THAT MAY BE	MAXIMUM NUMBER OF
	PURCHASED BY	SHARES THAT MAY BE
	EXERCISING	PURCHASED BY
PERIOD	NONSTATUTORY OPTIONS	EXERCISING ISOs
From Jan. 15, 2009 to Jan. 14, 2010	Up to 1,242 shares	None
From Jan. 15, 2010 to Jan. 21, 2018	Up to 2,483 shares (less any shares previously purchased by exercising Nonstatutory Options)	None

          If, during any of these periods, the Participant fails to exercise the Options with respect to all or any portion of the shares that may be acquired at such time, the Participant shall be entitled to exercise the Options with respect to the remaining portion of such shares at any subsequent time prior to the termination date of the Options.

          The Options intended to be ISOs are subject to the $100,000 annual limit on vesting of ISOs as set forth in Section 422(d) of the Code. To the extent the aggregate fair market value (determined at the date of grant) of the shares of Common Stock with respect to which those ISOs first become exercisable by the Participant during any calendar year under this Section 2 (when aggregated with any prior ISOs granted to the Participant under stock option plans of the Corporation) exceeds $100,000, whether by reason of accelerated vesting under Sections 9, 10 or 11 or otherwise, the Options shall consist of ISOs for the maximum number of shares that may be covered by ISOs without violating Section 422(d) of the Code, and the remaining Options becoming exercisable in that year shall be treated as Nonstatutory Options.

     3. Termination Date of Options.

          The Options granted herein, and the related Dividend Equivalent Rights under Section 8 below, shall terminate on January 21, 2018, the tenth anniversary of the date of grant, and the Participant shall have no right to exercise the Options at any time thereafter.

     4. Manner of Exercise.

          If the Participant elects to exercise the Options to purchase shares of Common Stock, the Participant shall give written notice of such exercise to the Corporate Secretary of the Corporation. The notice of exercise shall state the number of shares of Common Stock as to which the Options are being exercised, and the Corporation shall determine whether the Options exercised are ISOs or Nonstatutory Options.

          The Participant may exercise the Options to purchase all, or any lesser whole number, of the number of shares of Common Stock that the Participant is then permitted to purchase under Section 2.

2

     5. Payment for Shares.

          Full payment of the option price for the shares of Common Stock purchased by exercising the Options shall be due at the time the notice of exercise is delivered pursuant to Section 4. Such payment may be made (i) in cash, (ii) by delivery of shares of Common Stock currently owned by the Participant with a fair market value equal to the option price, or (iii) in any other form acceptable to the Corporation.

          Alternatively, the Participant shall be deemed to have paid the full option price due upon exercise of the Options, if the Participant’s notice of exercise is accompanied by an irrevocable instruction to the Corporation to deliver the shares of Common Stock issuable upon exercise of the Options (less any shares withheld to satisfy the Participant’s tax obligations pursuant to Section 7 below) promptly to a broker-dealer designated by Participant, together with an irrevocable instruction to such broker-dealer to sell at least that portion of the shares necessary to pay the option price (and any tax withholding related expenses specified by the parties), and that portion of the sale proceeds needed to pay the option price is delivered directly to the Corporation no later than the close of business on the settlement date.

     6. Issuance of Stock Certificates for Shares.

          The stock certificates (or other evidence of ownership) for any shares of Common Stock issuable to the Participant upon exercise of the Options shall be delivered to the Participant (or to the person to whom the rights of the Participant shall have passed by will or the laws of descent and distribution) as promptly after the date of exercise as is feasible, but not before the Participant has paid the option price for such shares and made any arrangements for tax withholding, as required by Section 7.

     7. Tax Withholding.

          Whenever the Participant exercises Options, the Corporation shall notify the Participant of the amount of tax (if any) that must be withheld by the Corporation under all applicable federal, state and local tax laws. With respect to each exercise of the Options, the Participant agrees to make arrangements with the Corporation to (a) remit the required amount to the Corporation in cash, (b) authorize the Corporation to withhold a portion of the shares of Common Stock otherwise issuable upon the exercise with a value equal to the required amount, (c) deliver to the Corporation shares of Common Stock with a value equal to the required amount, (d) authorize the deduction of the required amount from the Participant’s compensation, or (e) otherwise provide for payment of the required amount in any other manner satisfactory to the Corporation.

     8. Dividend Equivalent Rights.

          The Participant is hereby granted rights to receive deferred payments equivalent in value to the dividends that would have been payable on the shares of Common Stock issuable under the Options if such shares were outstanding on the dividend record dates between the date the Options were granted to the Participant and the date the Options are exercised to acquire

3

such shares (“Dividend Equivalent Rights”). An unfunded bookkeeping account shall be created for the Participant and the Participant’s rights to the balances credited to such account shall be no greater than those of an unsecured creditor of the Corporation.

          On each dividend record date occurring after the date of grant of the Options and while any Options remain outstanding and unexercised, the Participant’s account shall be credited with a dollar amount equal to the dividends that would have been payable with respect to the shares of Common Stock issuable under the Options if such shares were outstanding on the dividend record date:

     (a) In the case of a cash dividend declared on the Common Stock, the amount credited to the Participant’s account with respect thereto shall be equal to the dividend declared per share of Common Stock multiplied by the number of shares of Common Stock subject to the unexercised portion of the Options as of the dividend record date; and

     (b) In the case of a stock dividend declared on the Common Stock, the amount credited to the Participant’s account with respect thereto shall be equal to the dividend declared per share of Common Stock multiplied by (i) the number of shares of Common Stock subject to the unexercised portion of the Options and (ii) the current fair market value of a share of Common Stock on the dividend payment date.

          When the Options with respect to which the Participant has been granted Dividend Equivalent Rights first become exercisable (whether under Section 2 above or Sections 9, 10 or 11 below), the Participant shall be entitled to receive from the Corporation a distribution equal to (i) the dollar amount then accumulated in his or her account, as described above, and not previously distributed as provided in this paragraph, multiplied by (ii) a fraction the numerator of which shall be the number of shares subject to the Options that first become exercisable on such date and the denominator of which shall be the sum of such number and the total number of shares subject to Options that have not yet become exercisable; plus after shares have become exercisable (iii) distributions equal to the quarterly dividend declared per share of Common Stock multiplied by the number of shares of Common Stock that have become exercisable, which distributions shall be paid quarterly on or about the time of the dividend pay dates. The Participant’s account shall be debited by a dollar amount equal to the distribution. This distribution shall be delivered to the Participant in the form of a cash payment. No distribution shall be made until the Participant has made arrangements with the Corporation to withhold all applicable payroll taxes from the distribution, or to satisfy the tax withholding obligations in some other manner, as described in Section 7 above.

          Upon expiration or termination of the Options, all rights and claims to the Dividend Equivalent Rights will be terminated.

     9. Termination of Engagement; Change in Corporate Control.

          In the event of a Change in Corporate Control (as described below), or if the Participant’s engagement with the Corporation is terminated before the Options expire or have

4

been exercised with respect to all of the shares of Common Stock subject to the Options (as provided in subsections (a) and (b) below), the Participant shall have the right to exercise the Options during a period of ninety (90) days following the date of the Change in Corporate Control or termination of engagement (as applicable), but in no event later than January 21, 2018, and the Options shall expire at the end of such period.

     (a) In the event of a Change in Corporate Control, or if the Participant’s engagement is terminated involuntarily without “Cause” (as defined in the Participant’s Consulting Agreement), any portion of the Options not previously exercisable under Section 2 shall become immediately exercisable and the Participant shall be entitled to receive a cash payment of any balance then credited to the Participant’s Dividend Equivalent Rights account pursuant to Section 8.

     (b) In the case of an involuntary termination not described in subsection (a) above, or a voluntary termination by the Participant not following a Change in Corporate Control, the maximum number of shares the Participant may purchase by exercising the Options shall be the number of shares which could be purchased at the date of termination pursuant to Section 2. Participant shall not be entitled to receive a cash payment of any balance then credited to the Participant’s Dividend Equivalent Rights account pursuant to Section 8.

          For purposes of this Section 9, a “Change in Corporate Control” shall include any of the following events:

     (i) The acquisition in one or more transactions of more than twenty percent of the Corporation’s outstanding Common Stock (or the equivalent in voting power of any class or classes of securities of the Corporation entitled to vote in elections of directors) by any corporation, or other person or group (within the meaning of Section 14(d)(3) of the Securities Exchange Act of 1934, as amended);

     (ii) Any transfer or sale of substantially all of the assets of the Corporation, or any merger or consolidation of the Corporation into or with another corporation in which the Corporation is not the surviving entity;

     (iii) Any election of persons to the Board of Directors which causes a majority of the Board of Directors to consist of persons other than “Continuing Directors.” For this purpose, those persons who were members of the Board of Directors on January 21, 2008, shall be “Continuing Directors.” Any person who is nominated for election as a member of the Board after January 21, 2008 shall also be considered a “Continuing Director” for this purpose if, and only if, his or her nomination for election to the Board of Directors is approved or recommended by a majority of the members of the Board (or of the relevant Nominating Committee) and at least five (5) members of the Board are themselves Continuing Directors at the time of such nomination; or

     (iv) Any person, or group of persons, announces a tender offer for at least twenty percent (20%) of the Corporation’s Common Stock.

5

     10. Effect of Death.

          If the Participant dies before the Options expire or have been exercised with respect to all of the shares of Common Stock subject to the Options, any portion of the Options not previously exercisable under Section 2 shall become exercisable, and the Participant’s executor, administrator, or any person to whom the Options may be transferred by the Participant’s will or by the laws of descent and distribution, shall have the right to (i) exercise the Options, to the extent not previously exercised, at any time prior to the first anniversary of the date of death, but in no event later than January 21, 2018, and (ii) to receive a cash payment of any balance then credited to the Participant’s Dividend Equivalent Rights account pursuant to Section 8 above. For this purpose, the terms of this Agreement shall be deemed to apply to such person as if he or she was the Participant.

     11. Effect of Permanent and Total Disability or Retirement After Age 65.

          If the termination of the Participant’s engagement occurs after a finding of the Participant’s permanent and total disability, or as a result of retirement after age 65, (i) any portion of the Options not previously exercisable under Section 2 shall become exercisable, and the Options may be exercised at any time during the period of twelve (12) months following the date of termination of engagement, or retirement, as the case may be, but in no event later than January 21, 2018, and (ii) the Participant shall be entitled to receive a cash payment of any balance then credited to the Participant’s Dividend Equivalent Rights account pursuant to Section 8.

     12. Nontransferability.

          The Participant’s rights under this Agreement may not be assigned or transferred by the Participant other than by will or the laws of descent and distribution. The Options may not be exercised by anyone other than the Participant or, in the case of the Participant’s death, by the person to whom the rights of the Participant shall have passed by will or the laws of descent and distribution.

     13. Securities Laws.

          The Corporation may from time to time impose any conditions on the exercise of the Options as it deems necessary or advisable to ensure that the Options granted hereunder, and each exercise thereof, satisfy the applicable requirements of federal and state securities laws. Such conditions to satisfy applicable federal and state securities laws may include, without limitation, the partial or complete suspension of the right to exercise the Options until the offering of the shares covered by the Options have been registered under the Securities Act of 1933, as amended, or the printing of legends on all stock certificates issued to the Participant describing the restrictions on transfer of such shares.

6

     14. Rights Prior to Issuance of Certificates.

          Neither the Participant nor any person to whom the rights of the Participant shall have passed by will or the laws of descent and distribution shall have any of the rights of a stockholder with respect to any shares of Common Stock until the date of the issuance to him or her of certificates (or other evidence of ownership) for such Common Stock as provided in Section 6 above.

     15. Options Not to Affect Engagement.

          Neither this Agreement nor the Options granted hereunder shall confer upon the Participant any right to a continuing engagement with the Corporation. This Agreement shall not in any way modify or restrict any rights the Corporation may have to terminate such engagement under the terms of the Participant’s Consulting Agreement.

     16. Miscellaneous.

          (a) This Agreement may be executed in one or more counterparts all of which taken together will constitute one and the same instrument.

          (b) The terms of this Agreement may only be amended, modified or waived by a written agreement executed by both of the parties hereto.

          (c) The validity, performance, construction and effect of this Agreement shall be governed by the laws of the State of Ohio, without giving effect to principles of conflicts of law; provided, however, that matters of corporate law, including the issuance of shares of the Common Stock, shall be governed by the Delaware General Corporation Law.

     IN WITNESS WHEREOF, the parties have executed this Agreement on the date and year first above written.

ATTEST:	HEALTH CARE REIT, INC.
/s/ Erin C. Ibele Senior Vice President-Administration	By: /s/ George L. Chapman        Chairman and
and Corporate Secretary	Chief Executive Officer
/s/ Erin C. Ibele	/s/ Frederick L. Farrar
	Frederick L. Farrar

7

EX-10.2

EXHIBIT 10.2

STOCK OPTION AGREEMENT

     THIS STOCK OPTION AGREEMENT (the “Agreement”), made this 21st day of January, 2008 between Health Care REIT, Inc., a Delaware corporation (the “Corporation”), and Frederick L. Farrar (the “Participant”).

WITNESSETH:

     WHEREAS, the Participant is an executive officer of the Corporation; and

     WHEREAS, the Corporation adopted the Health Care REIT, Inc. 2005 Long-Term Incentive Plan (the “Plan”) in order to provide non-employee directors and select officers and key employees with incentives to achieve long-term corporate objectives; and

     WHEREAS, the Compensation Committee of the Corporation’s Board of Directors decided that the Participant should be granted stock options to purchase shares of the Corporation’s common stock, $1.00 par value per share (“Common Stock”), on the terms and conditions set forth below, and in accordance with the terms of the Plan.

     NOW, THEREFORE, in consideration of the covenants and agreements herein contained and intending to be legally bound hereby, the parties hereto agree as follows:

     1. Grant of Options.

          Subject to the terms and conditions of this Agreement, the Corporation hereby grants to the Participant the right and option to purchase up to a total of 12,210 shares of the Common Stock of the Corporation, at the option price of $40.83 per share (the “Options”).

          The Options shall consist of options to purchase 0 shares of Common Stock intended to qualify as incentive stock options (“ISOs”) within the meaning of Section 422 of the Internal Revenue Code of 1986, as amended (the “Code”), and options to purchase 12,210 shares of Common Stock not intended to qualify as ISOs (“Nonstatutory Options”).

     2. Period of Exercise.

          The Options shall become exercisable by the Participant in two installments. Subject to the accelerated vesting provided for in Sections 8, 9 and 10 below, at any time during the term of the Options, the maximum number of shares of Common Stock the Participant may purchase by exercising Nonstatutory Options, and the maximum number which the Participant may purchase by exercising ISOs, shall be limited as specified in the following schedule:

	MAXIMUM NUMBER OF
	SHARES THAT MAY BE	MAXIMUM NUMBER OF
	PURCHASED BY	SHARES THAT MAY BE
	EXERCISING	PURCHASED BY
PERIOD	NONSTATUTORY OPTIONS	EXERCISING ISOs
From Jan. 15, 2009 to Jan. 14, 2010	Up to 6,105 shares	None
From Jan. 15, 2010 to Jan. 21, 2018	Up to 12,210 shares (less any shares previously purchased by exercising Nonstatutory Options)	None

          If, during any of these periods, the Participant fails to exercise the Options with respect to all or any portion of the shares that may be acquired at such time, the Participant shall be entitled to exercise the Options with respect to the remaining portion of such shares at any subsequent time prior to the termination date of the Options.

          The Options intended to be ISOs are subject to the $100,000 annual limit on vesting of ISOs as set forth in Section 422(d) of the Code. To the extent the aggregate fair market value (determined at the date of grant) of the shares of Common Stock with respect to which those ISOs first become exercisable by the Participant during any calendar year under this Section 2 (when aggregated with any prior ISOs granted to the Participant under stock option plans of the Corporation) exceeds $100,000, whether by reason of accelerated vesting under Sections 8, 9 or 10 or otherwise, the Options shall consist of ISOs for the maximum number of shares that may be covered by ISOs without violating Section 422(d) of the Code, and the remaining Options becoming exercisable in that year shall be treated as Nonstatutory Options.

     3. Termination Date of Options.

          The Options granted herein shall terminate on January 21, 2018, the tenth anniversary of the date of grant, and the Participant shall have no right to exercise the Options at any time thereafter.

     4. Manner of Exercise.

          If the Participant elects to exercise the Options to purchase shares of Common Stock, the Participant shall give written notice of such exercise to the Corporate Secretary of the Corporation. The notice of exercise shall state the number of shares of Common Stock as to which the Options are being exercised, and the Corporation shall determine whether the Options exercised are ISOs or Nonstatutory Options.

          The Participant may exercise the Options to purchase all, or any lesser whole number, of the number of shares of Common Stock that the Participant is then permitted to purchase under Section 2.

2

     5. Payment for Shares.

          Full payment of the option price for the shares of Common Stock purchased by exercising the Options shall be due at the time the notice of exercise is delivered pursuant to Section 4. Such payment may be made (i) in cash, (ii) by delivery of shares of Common Stock currently owned by the Participant with a fair market value equal to the option price, or (iii) in any other form acceptable to the Corporation.

          Alternatively, the Participant shall be deemed to have paid the full option price due upon exercise of the Options, if the Participant’s notice of exercise is accompanied by an irrevocable instruction to the Corporation to deliver the shares of Common Stock issuable upon exercise of the Options (less any shares withheld to satisfy the Participant’s tax obligations pursuant to Section 7 below) promptly to a broker-dealer designated by Participant, together with an irrevocable instruction to such broker-dealer to sell at least that portion of the shares necessary to pay the option price (and any tax withholding related expenses specified by the parties), and that portion of the sale proceeds needed to pay the option price is delivered directly to the Corporation no later than the close of business on the settlement date.

     6. Issuance of Stock Certificates for Shares.

          The stock certificates (or other evidence of ownership) for any shares of Common Stock issuable to the Participant upon exercise of the Options shall be delivered to the Participant (or to the person to whom the rights of the Participant shall have passed by will or the laws of descent and distribution) as promptly after the date of exercise as is feasible, but not before the Participant has paid the option price for such shares and made any arrangements for tax withholding, as required by Section 7.

     7. Tax Withholding.

          Whenever the Participant exercises Options, the Corporation shall notify the Participant of the amount of tax (if any) that must be withheld by the Corporation under all applicable federal, state and local tax laws. With respect to each exercise of the Options, the Participant agrees to make arrangements with the Corporation to (a) remit the required amount to the Corporation in cash, (b) authorize the Corporation to withhold a portion of the shares of Common Stock otherwise issuable upon the exercise with a value equal to the required amount, (c) deliver to the Corporation shares of Common Stock with a value equal to the required amount, (d) authorize the deduction of the required amount from the Participant’s compensation, or (e) otherwise provide for payment of the required amount in any other manner satisfactory to the Corporation.

     8. Termination of Engagement; Change in Corporate Control.

          In the event of a Change in Corporate Control (as described below), or if the Participant’s engagement with the Corporation is terminated before the Options expire or have been exercised with respect to all of the shares of Common Stock subject to the Options (as provided in subsections (a) and (b) below), the Participant shall have the right to exercise the

3

Options during a period of ninety (90) days following the date of the Change in Corporate Control or termination of engagement (as applicable), but in no event later than January 21, 2018, and the Options shall expire at the end of such period.

     (a) In the event of a Change in Corporate Control, or if the Participant’s engagement is terminated involuntarily without “Cause” (as defined in the Participant’s Consulting Agreement), any portion of the Options not previously exercisable under Section 2 shall become immediately exercisable.

     (b) In the case of an involuntary termination not described in subsection (a) above, or a voluntary termination by the Participant not following a Change in Corporate Control, the maximum number of shares the Participant may purchase by exercising the Options shall be the number of shares which could be purchased at the date of termination pursuant to Section 2.

          For purposes of this Section 8, a “Change in Corporate Control” shall include any of the following events:

     (i) The acquisition in one or more transactions of more than twenty percent of the Corporation’s outstanding Common Stock (or the equivalent in voting power of any class or classes of securities of the Corporation entitled to vote in elections of directors) by any corporation, or other person or group (within the meaning of Section 14(d)(3) of the Securities Exchange Act of 1934, as amended);

     (ii) Any transfer or sale of substantially all of the assets of the Corporation, or any merger or consolidation of the Corporation into or with another corporation in which the Corporation is not the surviving entity;

     (iii) Any election of persons to the Board of Directors which causes a majority of the Board of Directors to consist of persons other than “Continuing Directors.” For this purpose, those persons who were members of the Board of Directors on January 21, 2008 shall be “Continuing Directors.” Any person who is nominated for election as a member of the Board after January 21, 2008 shall also be considered a “Continuing Director” for this purpose if, and only if, his or her nomination for election to the Board of Directors is approved or recommended by a majority of the members of the Board (or of the relevant Nominating Committee) and at least five (5) members of the Board are themselves Continuing Directors at the time of such nomination; or

     (iv) Any person, or group of persons, announces a tender offer for at least twenty percent (20%) of the Corporation’s Common Stock.

     9. Effect of Death.

          If the Participant dies before the Options expire or have been exercised with respect to all of the shares of Common Stock subject to the Options, any portion of the Options not previously exercisable under Section 2 shall become exercisable, and the Participant’s

4

executor, administrator, or any person to whom the Options may be transferred by the Participant’s will or by the laws of descent and distribution, shall have the right to exercise the Options, to the extent not previously exercised, at any time prior to the first anniversary of the date of death, but in no event later than January 21, 2018. For this purpose, the terms of this Agreement shall be deemed to apply to such person as if he or she was the Participant.

     10. Effect of Permanent and Total Disability or Retirement After Age 65.

          If the termination of the Participant’s engagement occurs after a finding of the Participant’s permanent and total disability, or as a result of retirement after age 65, any portion of the Options not previously exercisable under Section 2 shall become exercisable, and the Options may be exercised at any time during the period of twelve (12) months following the date of termination of engagement, or retirement, as the case may be, but in no event later than January 21, 2018.

     11. Nontransferability.

          The Participant’s rights under this Agreement may not be assigned or transferred by the Participant other than by will or the laws of descent and distribution. The Options may not be exercised by anyone other than the Participant or, in the case of the Participant’s death, by the person to whom the rights of the Participant shall have passed by will or the laws of descent and distribution.

     12. Securities Laws.

          The Corporation may from time to time impose any conditions on the exercise of the Options as it deems necessary or advisable to ensure that the Options granted hereunder, and each exercise thereof, satisfy the applicable requirements of federal and state securities laws. Such conditions to satisfy applicable federal and state securities laws may include, without limitation, the partial or complete suspension of the right to exercise the Options until the offering of the shares covered by the Options have been registered under the Securities Act of 1933, as amended, or the printing of legends on all stock certificates issued to the Participant describing the restrictions on transfer of such shares.

     13. Rights Prior to Issuance of Certificates.

          Neither the Participant nor any person to whom the rights of the Participant shall have passed by will or the laws of descent and distribution shall have any of the rights of a stockholder with respect to any shares of Common Stock until the date of the issuance to him or her of certificates (or other evidence of ownership) for such Common Stock as provided in Section 6 above.

     14. Options Not to Affect Engagement.

          Neither this Agreement nor the Options granted hereunder shall confer upon the Participant any right to a continuing engagement with the Corporation. This Agreement shall

5

not in any way modify or restrict any rights the Corporation may have to terminate such engagement under the terms of the Participant’s Consulting Agreement.

     15. Miscellaneous.

          (a) This Agreement may be executed in one or more counterparts all of which taken together will constitute one and the same instrument.

          (b) The terms of this Agreement may only be amended, modified or waived by a written agreement executed by both of the parties hereto.

          (c) The validity, performance, construction and effect of this Agreement shall be governed by the laws of the State of Ohio, without giving effect to principles of conflicts of law; provided, however, that matters of corporate law, including the issuance of shares of the Common Stock, shall be governed by the Delaware General Corporation Law.

     IN WITNESS WHEREOF, the parties have executed this Agreement on the date and year first above written.

ATTEST:	HEALTH CARE REIT, INC.
/s/ Erin C. Ibele Senior Vice President-Administration	By: /s/ George L. Chapman        Chairman and
and Corporate Secretary	Chief Executive Officer
/s/ Erin C. Ibele	/s/ Frederick L. Farrar
	Frederick L. Farrar

6

EX-10.3

EXHIBIT 10.3

RESTRICTED STOCK AGREEMENT

     THIS RESTRICTED STOCK AGREEMENT (the “Agreement”), made this 21st day of January, 2008, between Health Care REIT, Inc., a Delaware corporation (the “Corporation”), and Frederick L. Farrar (the “Participant”).

WITNESSETH:

     WHEREAS, the Participant is an executive officer of the Corporation; and

     WHEREAS, the Corporation adopted the Health Care REIT, Inc. 2005 Long-Term Incentive Plan (the “Plan”) in order to provide non-employee directors and select officers and key employees with incentives to achieve long-term corporate objectives; and

     WHEREAS, the Compensation Committee of the Corporation’s Board of Directors has decided that the Participant should be granted restricted shares of the Corporation’s common stock, $1.00 par value per share (“Common Stock”), on the terms and conditions set forth below in accordance with the terms of the Plan.

     NOW, THEREFORE, in consideration of the past and future services provided to the Corporation by the Participant and the various covenants and agreements herein contained, and intending to be legally bound hereby, the parties hereto agree as follows:

     1. Grant of Restricted Stock.

          The Corporation hereby grants to the Participant a total of 6,746 shares of the Common Stock of the Corporation (the “Restricted Shares”), subject to the transfer restrictions, vesting schedule and other conditions set forth in this Agreement. The Participant shall not be required to provide the Corporation with any payment (other than his or her past and future services to the Corporation) in exchange for such Restricted Shares.

          As provided in Section 4, the Corporation shall cause the Restricted Shares to be issued in book entry form and registered in the name of the Participant promptly upon execution of this Agreement. On or before the date of execution of this Agreement (if required by the Corporation), the Participant shall deliver to the Corporation one or more stock powers endorsed in blank relating to the Restricted Shares.

     2. Restrictions.

          (a) The Participant shall have all rights and privileges of a stockholder of the Corporation with respect to the Restricted Shares, including voting rights and the right to receive dividends paid with respect to the Restricted Shares, except that the following restrictions shall apply until such time or times as these restrictions lapse under Section 3 or any other provision of this Agreement:

     (i) the Participant shall not be entitled to delivery of any certificates for any of the Restricted Shares until the restrictions imposed by this Agreement have lapsed with respect to those Restricted Shares;

     (ii) the Restricted Shares may not be sold, transferred, assigned, pledged or otherwise encumbered or disposed of by the Participant before these restrictions have lapsed, except with the consent of the Corporation; and

     (iii) the Restricted Shares shall be subject to forfeiture upon termination of the Participant’s engagement with the Corporation to the extent set forth in Section 6 below.

If any portion of the Restricted Shares become vested under Section 3 below (or Sections 6, 7 or 8), such newly vested shares shall no longer be subject to the preceding restrictions.

          (b) Any attempt to dispose of Restricted Shares in a manner contrary to the restrictions set forth in this Agreement shall be ineffective.

     3. Vesting; When Restrictions Lapse.

          The Restricted Shares shall vest in two annual installments, on January 15, 2009 and January 15, 2010, or at such earlier time as the restrictions may lapse pursuant to Sections 6, 7 or 8 of this Agreement. In the absence of any accelerated vesting and lapse of the restrictions under Sections 6, 7 or 8, the restrictions set forth in this Agreement shall lapse with respect to the following numbers of shares on the following dates:

	NUMBER OF SHARES
DATE	THAT BECOME VESTED
January 15, 2009	3,373 shares
January 15, 2010	3,373 shares

     4. Issuance of Shares.

          The book entry for the Restricted Shares shall bear the following legend:

“The transferability of the shares of stock represented hereby are subject to the terms and conditions (including possible forfeiture) of a Restricted Stock Agreement entered into between the registered owner and Health Care REIT, Inc. A copy of such Restricted Stock Agreement is on file in the offices of the Corporate Secretary, Health Care REIT, Inc., One SeaGate, Suite 1500, Toledo, Ohio 43604.”

Once the restrictions imposed by this Agreement have lapsed with respect to any portion of the Restricted Shares, the book entry for such portion of the Restricted Shares shall be modified to remove the foregoing legend, but not before the Participant has made arrangements satisfactory

2

to the Corporation for tax withholding (as required by Section 5), and the portion of the newly vested shares (if any) that the Participant applies to satisfy his or her tax withholding obligations pursuant to Section 5(b) below shall be transferred to the treasury of the Corporation.

     5. Tax Withholding.

          Whenever the restrictions applicable to all or a portion of the Restricted Shares lapse under the terms of this Agreement, the Corporation shall notify the Participant of the amount of tax that must be withheld by the Corporation under all applicable federal, state and local tax laws. The Participant agrees to make arrangements with the Corporation to (a) remit the required amount to the Corporation in cash, (b) deliver to the Corporation shares of Common Stock currently held by the Participant (including newly vested shares) with a value equal to the required amount, (c) authorize the deduction of the required amount from the Participant’s compensation, or (d) otherwise provide for payment of the required amount in a manner satisfactory to the Corporation.

     6. Termination of Engagement; Change in Corporate Control.

          If the Participant’s engagement with the Corporation is involuntarily terminated for “Cause” (as defined in the Participant’s Consulting Agreement) during the term of this Agreement, or if the Participant voluntarily terminates his or her engagement with the Corporation (other than after a Change in Corporate Control (as described below) occurring after the date hereof or as provided in Sections 7 or 8 below), any Restricted Shares that remain subject to the restrictions imposed by this Agreement shall be forfeited.

          If the Participant’s engagement is terminated involuntarily without Cause, or in the event of a Change in Corporate Control, vesting shall be accelerated, the restrictions imposed by this Agreement on the remaining Restricted Shares shall lapse immediately, and no Restricted Shares shall be forfeited.

          For purposes of this Section 6, a “Change in Corporate Control” shall include any of the following events:

     (a) The acquisition in one or more transactions of more than twenty percent of the Corporation’s outstanding Common Stock (or the equivalent in voting power of any class or classes of securities of the Corporation entitled to vote in elections of directors) by any corporation, or other person or group (within the meaning of Section 14(d)(3) of the Securities Exchange Act of 1934, as amended);

     (b) Any transfer or sale of substantially all of the assets of the Corporation, or any merger or consolidation of the Corporation into or with another corporation in which the Corporation is not the surviving entity;

     (c) Any election of persons to the Board of Directors which causes a majority of the Board of Directors to consist of persons other than “Continuing Directors.” For this purpose, those persons who were members of the Board of Directors on January 21,

3

2008, shall be “Continuing Directors.” Any person who is nominated for election as a member of the Board after January 21, 2008 shall also be considered a “Continuing Director” for this purpose if, and only if, his or her nomination for election to the Board of Directors is approved or recommended by a majority of the members of the Board (or of the relevant Nominating Committee) and at least five (5) members of the Board are themselves Continuing Directors at the time of such nomination; or

     (d) Any person, or group of persons, announces a tender offer for at least twenty percent (20%) of the Corporation’s Common Stock.

     7. Effect of Death.

          If the termination of the Participant’s engagement occurs as a result of the Participant’s death, vesting shall be accelerated and all of the restrictions imposed on the Restricted Shares by this Agreement shall lapse immediately.

     8. Effect of Permanent and Total Disability or Retirement After Age 65.

          If the termination of the Participant’s engagement occurs after a finding of the Participant’s permanent and total disability, or as a result of retirement after age 65, vesting shall be accelerated and all of the restrictions imposed on the Restricted Shares by this Agreement shall lapse immediately.

     9. Securities Laws.

          The Corporation may from time to time impose such conditions on the transfer of the Restricted Shares as it deems necessary or advisable to ensure that any transfers of the Restricted Shares will satisfy the applicable requirements of federal and state securities laws. Such conditions may include, without limitation, the partial or complete suspension of the right to transfer the Restricted Shares until the Restricted Shares have been registered under the Securities Act of 1933, as amended.

     10. Grant Not to Affect Engagement.

          Neither this Agreement nor the Restricted Shares granted hereunder shall confer upon the Participant any right to a continuing engagement with the Corporation. This Agreement shall not in any way modify or restrict any rights the Corporation may have to terminate such engagement under the terms of the Participant’s Consulting Agreement with the Corporation.

     11. Miscellaneous.

          (a) This Agreement may be executed in one or more counterparts, all of which taken together will constitute one and the same instrument.

4

          (b) The terms of this Agreement may only be amended, modified or waived by a written agreement executed by both of the parties hereto.

          (c) The validity, performance, construction and effect of this Agreement shall be governed by the laws of the State of Ohio, without giving effect to principles of conflicts of law; provided, however, that matters of corporate law, including the issuance of shares of Common Stock, shall be governed by the Delaware General Corporation Law.

     IN WITNESS WHEREOF, the parties have executed this Agreement on the date and year first above written.

ATTEST:	HEALTH CARE REIT, INC.
/s/ Erin C. Ibele Senior Vice President-Administration	By:	/s/ George L. Chapman       Chairman and
and Corporate Secretary		Chief Executive Officer
/s/ Erin C. Ibele	/s/ Frederick L. Farrar
	Frederick L. Farrar

5

EX-10.4

EXHIBIT 10.4

AMENDED AND RESTATED
EMPLOYMENT AGREEMENT

          THIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT, dated this 18th day of June, 2008 (the “Agreement”), is entered into by and between HEALTH CARE REIT, INC., a Delaware corporation, (the “Corporation”), and DANIEL R. LOFTUS (the “Executive”).

          WHEREAS, the Corporation and the Executive entered into an Employment Agreement, effective as of December 20, 2006;

          WHEREAS, the Compensation Committee of the Corporation’s Board of Directors has approved certain modifications to the terms of such Employment Agreement; and

          WHEREAS, the Corporation wishes to assure itself of the services of the Executive for the period provided in this Agreement and the Executive is willing to serve in the employ of the Corporation for such period upon the terms and conditions set forth in this Agreement.

          NOW THEREFORE, in consideration of the mutual covenants herein contained, the parties, intending to be legally bound, hereby agree as follows:

     1. EMPLOYMENT

          The Corporation hereby agrees to employ the Executive as a Senior Vice President upon the terms and conditions herein contained, and the Executive hereby agrees to accept such employment and to serve in such position, and to perform the duties and functions customarily performed by a Senior Vice President of a publicly traded corporation during the term of this Agreement. In such capacity, the Executive shall report to the head of the Medical Facilities Group and to the Corporation’s Chief Executive Officer (the “CEO”) and Board of Directors and shall have such powers and responsibilities consistent with his position as may be assigned.

          Throughout the term of this Agreement, the Executive shall devote his best efforts and all of his business time and services to the business and affairs of the Corporation.

     2. TERM OF AGREEMENT

          The current term of employment under this Agreement shall expire on January 31, 2011. Upon the expiration of such term, the term of employment hereunder shall automatically be extended without further action by the parties for successive two (2) year renewal terms, unless either party shall give at least six (6) months advance written notice to the other of his or its intention that this Agreement shall terminate upon the expiration of the current term or the then current renewal term, as the case may be.

          Notwithstanding the foregoing, the Corporation shall be entitled to terminate this Agreement immediately, subject to a continuing obligation to make any payments required under

Section 5 below, if the Executive (i) becomes disabled as described in Section 5(b), (ii) is terminated for Cause, as defined in Section 5(c), or (iii) voluntarily terminates his employment before the current term of this Agreement expires, as described in Section 5(d).

     3. SALARY AND BONUS

          The Executive shall receive a base salary during the term of this Agreement at a rate of not less than $267,800 per annum for 2008, and at a rate of not less than $267,800 per annum for subsequent years, payable in substantially equal semi-monthly installments. The Compensation Committee of the Board shall consult with the CEO and review the Executive’s base salary at annual intervals, and may adjust the Executive’s annual base salary from time to time as the Committee deems to be appropriate.

          The Executive shall also be eligible to receive a bonus from the Corporation each year during the term of this Agreement, with the actual amount of such bonus to be determined by the Compensation Committee of the Corporation’s Board, using such performance measures as the Committee deems to be appropriate.

          On the date of this Agreement, the Executive shall receive a grant of shares of the Corporation’s common stock having a value of $150,000, based on the closing price of the Corporation’s common stock on the date of this Agreement. One-half of such shares shall be fully vested on the date of this Agreement and one-half shall vest on January 15, 2009.

     4. ADDITIONAL COMPENSATION AND BENEFITS

          The Executive shall receive the following additional compensation and welfare and fringe benefits:

     (a) Stock Options and Other Long-Term Incentives. The Executive has been granted incentive stock options, nonstatutory stock options and shares of restricted stock pursuant to the terms of the Corporation’s 2005 Long-Term Incentive Plan. During the remaining term of the Agreement, any additional stock options, restricted stock or other awards granted under the 2005 Long-Term Incentive Plan shall be at the discretion of the Compensation Committee of the Corporation’s Board.

     (b) Health Insurance. The Corporation shall provide the Executive and his dependents with health insurance, life insurance and disability coverage on terms no less favorable than that from time to time made available to other key employees.

     (c) Vacation. The Executive shall be entitled to up to three (3) weeks of vacation during each year during the term of this Agreement and any extensions thereof, prorated for partial years.

     (d) Business Expenses. The Corporation shall reimburse the Executive for all reasonable expenses he incurs in promoting the Corporation’s business, including expenses

2

for travel and similar items, upon presentation by the Executive from time to time of an itemized account of such expenditures.

          In addition to the benefits provided pursuant to the preceding paragraphs of this Section 4, the Executive shall be eligible to participate in such other executive compensation and retirement plans of the Corporation as are applicable generally to other officers, and in such welfare benefit plans, programs, practices and policies of the Corporation as are generally applicable to other key employees, unless such participation would duplicate, directly or indirectly, benefits already accorded to the Executive.

     5. PAYMENTS UPON TERMINATION

          (a) Involuntary Termination. If the Executive’s employment is terminated by the Corporation during the term of this Agreement, the Executive shall be entitled to receive his base salary accrued through the date of termination, any accrued but unpaid vacation pay, plus any bonuses earned but unpaid with respect to fiscal years or other periods preceding the termination date. The Executive shall also receive any nonforfeitable benefits payable to him under the terms of any deferred compensation, incentive or other benefit plans maintained by the Corporation, payable in accordance with the terms of the applicable plan.

          If the termination is not a termination for Cause, as described in paragraph (c), a voluntary termination by the Executive as described in paragraph (d), or a result of the Executive’s death or disability, then the Corporation shall also be obligated to make a series of monthly severance payments to the Executive for each month during the remaining term of this Agreement, but not less than twelve (12) months. Each monthly payment shall be equal to one-twelfth (1/12th) of the sum of (i) the Executive’s annual base salary, as in effect on the date of termination, and (ii) the average of the annual bonuses paid to the Executive for the prior three fiscal years preceding the termination date. If the Executive obtains a replacement position with any new employer (including a position as an officer, employee, consultant, or agent, or self-employment as a partner or sole proprietor), the payments shall be reduced by all amounts the Executive receives as compensation for services performed during such period. The Executive shall be under no duty to mitigate the amounts owed to him under this paragraph (a) by seeking such a replacement position.

          Notwithstanding the preceding paragraph, if the Executive is a “specified employee” of the Corporation (or its successor) at the date of the termination, the amount of monthly severance payments which may be paid to the Executive within the first six (6) months after the date of the termination of employment shall be limited to two (2) times the lesser of (i) the Executive’s annualized compensation from the Corporation for the calendar year preceding the year of the termination, or (ii) $230,000 or such higher annual limit on the maximum annual compensation taken into account by a qualified retirement plan under Section 401(a)(17) of the Internal Revenue Code (the “Code”) as may be in effect for the year of the termination date. Any portion of the severance benefits which would otherwise have been paid to the Executive within the first six (6) months after the date of the Executive’s “separation from service” with the Corporation (as that term is defined under Section 409A of the Code and Treasury Regulation 1.409A-1(h) but for the delay imposed by this paragraph shall instead be paid to the Executive, together with interest at an annual rate equal to the interest rate specified by KeyBank for a six-

3

month certificate of deposit, on the first day of the first calendar month beginning at least six months following the date of the termination, or, if the Executive should die before that date, be paid to the Executive’s surviving spouse (or such other beneficiary as the Executive may designate in writing), as promptly as practicable after the date of death. For this purpose, a termination of the Executive’s employment shall be treated as a separation from service only if it reduces the level of services the Executive is anticipated to provide to the Corporation (whether as an employee or consultant) to less than twenty percent (20%) of the average level of bona fide services the Executive provided to the Corporation during the immediately preceding thirty-six (36) months. For this purpose, the Executive shall be considered a “specified employee” only if the Executive was a “key employee” of the Corporation within the meaning of Code Section 416(i) (without regard to paragraph (5) thereof) on December 31 of the prior calendar year. This limitation has been inserted solely in order to comply with the requirements of Section 409A(a)(2)(B) of the Code, and shall not apply if at the date of the Executive’s termination no stock of the Corporation (or its successor) is publicly traded on an established securities market or if Section 409A(a)(2)(B) of the Code is not then applicable to the Executive for any other reason.

          In addition, if the termination is not a termination for Cause as described in paragraph (c), a voluntary termination by the Executive as described in paragraph (d), or a result of the Executive’s death or disability, then:

     (i) Any stock options, restricted stock or other awards granted to the Executive under the Corporation’s 2005 Long-Term Incentive Plan shall become fully vested and, in the case of stock options, exercisable in full; and

     (ii) The Executive shall be provided continued coverage at the Corporation’s expense under any life, health and disability insurance programs maintained by the Corporation in which the Executive participated at the time of his termination for the remaining term of the Agreement (but not less than six (6) months), or until, if earlier, the date the Executive obtains comparable coverage under benefit plans maintained by a new employer.

          (b) Disability. The Corporation shall be entitled to terminate this Agreement, if the Board determines that the Executive has been unable to attend to his duties for at least ninety (90) days because of a medically diagnosable physical or mental condition, and has received a written opinion from a physician acceptable to the Board that such condition prevents the Executive from resuming full performance of his duties and is likely to continue for an indefinite period. Upon such termination, the Executive shall be entitled to receive his base salary accrued through the date of termination, any accrued but unpaid vacation pay, plus any bonuses earned but unpaid with respect to fiscal years or other periods preceding the termination date. In addition, the Corporation shall make a series of monthly disability payments to Executive, each equal to one-twelfth (1/12^th) of the sum of (i) his annual base salary, as in effect at the time Executive became permanently disabled, and (ii) the average of the annual bonuses paid to the Executive for the prior three fiscal years preceding the date of disability. Payment of such disability benefit shall commence with the month following the date of the termination by reason of permanent disability and continue each month for the remaining current term of this Agreement (but not less than twelve (12) months), but shall

4

terminate at an earlier date if the Executive returns to active employment, either with the Corporation or otherwise. Any amounts payable under this Section 5(b) shall be reduced by any amounts paid to the Executive under any long-term disability plan or other disability program or insurance policies maintained or provided by the Corporation.

          (c) Termination for Cause. If the Executive’s employment is terminated by the Corporation for Cause, the amount the Executive shall be entitled to receive from the Corporation shall be limited to his base salary accrued through the date of termination, any accrued but unpaid vacation pay, plus any bonuses earned but unpaid with respect to the fiscal year of the Corporation most recently ended, and any nonforfeitable benefits payable to the Executive under the terms of any deferred compensation, incentive or other benefit plans maintained by the Corporation.

          For purposes of this Agreement, the term “Cause” shall be limited to (i) action by the Executive involving willful disloyalty to the Corporation, such as embezzlement, fraud, misappropriation of corporate assets or a breach of the covenants set forth in Sections 9 and 10 below; or (ii) the Executive being convicted of a felony; or (iii) the Executive being convicted of any lesser crime or offense committed in connection with the performance of his duties hereunder or involving moral turpitude; or (iv) the intentional and willful failure by the Executive to substantially perform his duties hereunder as directed by the Corporation’s CEO or President (other than any such failure resulting from the Executive’s incapacity due to physical or mental disability) after a demand for substantial performance is made on the Executive by the Board of Directors.

          (d) Voluntary Termination by the Executive. If the Executive resigns or otherwise voluntarily terminates his employment before the end of the current term of this Agreement (other than in connection with a Change in Corporate Control, as described in Section 6), the amount the Executive shall be entitled to receive from the Corporation shall be limited to his base salary accrued through the date of termination, any accrued but unpaid vacation pay, plus any bonuses earned but unpaid with respect to any fiscal years or other periods preceding the termination date, and any nonforfeitable benefits payable to the Executive under the terms of any deferred compensation, incentive or other benefit plans of the Corporation.

          For purposes of this paragraph, a resignation by the Executive shall not be deemed to be voluntary if, without the Executive’s prior written consent, the Executive is (1) assigned to a position other than the Senior Vice President of the Corporation (other than for Cause or by reason of permanent disability), (2) assigned duties materially inconsistent with such position, or (3) directed to report to anyone other than the head of the Medical Facilities Group or the Corporation’s CEO or Board of Directors; provided that the Executive has notified the Corporation within the first ninety (90) days following the date of such change in assignment or reporting duties that the Executive regards such change in assignment or reporting duties as grounds justifying resignation under this paragraph and the Corporation has failed to cure such change in assignment or reporting duties within thirty (30) days following its receipt of such notice from the Executive.

5

     6. EFFECT OF CHANGE IN CORPORATE CONTROL

          (a) In the event of a Change in Corporate Control, the vesting of any stock options, restricted stock or other awards granted to the Executive under the terms of the Corporation’s 2005 Long-Term Incentive Plan shall be accelerated (to the extent permitted by the terms of such plans) and such awards shall become immediately vested in full and, in the case of stock options, exercisable in full.

          (b) If, at any time during the period of twelve (12) consecutive months following the occurrence of a Change in Corporate Control, and during the term of this Agreement, the Executive is involuntarily terminated (other than for Cause), the Executive shall be entitled to receive a lump sum severance payment equal to the present value of a series of monthly payments for twenty-four (24) months, each in an amount equal to one-twelfth (1/12th) of the sum of (i) the Executive’s annual base salary, as in effect at the time of the Change in Corporate Control, and (ii) the average of the annual bonuses paid to the Executive for the prior three fiscal years of the Corporation ending prior to the Change in Corporate Control. Such present value shall be calculated using a discount rate equal to the interest rate on 90-day Treasury bills, as reported in the Wall Street Journal (or similar publication) on the date of the Change in Corporate Control.

          In addition, if the Executive is involuntarily terminated (other than for Cause) within twelve (12) months after a Change in Corporate Control, he shall be entitled to continued coverage at the Corporation’s expense under any life, health and disability insurance programs maintained by the Corporation in which the Executive participated at the time of his termination, which coverage shall be continued until the expiration of the current term of the Agreement (but not less than six (6) months) or until, if earlier, the date the Executive obtains comparable coverage under benefit plans maintained by a new employer.

          (c) For purposes of this Agreement, a “Change in Corporate Control” shall include any of the following events:

(i) The acquisition in one or more transactions of more than twenty percent (20%) of the Corporation’s outstanding Common Stock (or the equivalent in voting power of any class or classes of securities of the Corporation entitled to vote in elections of directors) by any corporation, or other person or group (within the meaning of Section 14(d)(3) of the Securities Exchange Act of 1934, as amended);

(ii) Any transfer or sale of substantially all of the assets of the Corporation, or any merger or consolidation of the Corporation into or with another corporation in which the Corporation is not the surviving entity;

(iii) Any election of persons to the Board of Directors which causes a majority of the Board of Directors to consist of persons other than “Continuing Directors”. For this purpose, those persons who were members of the Board of Directors on May 1, 2008, shall be “Continuing Directors”. Any person who is nominated for election as a member of the Board after May 1, 2008, shall also be considered a “Continuing Director” for this purpose if, and only if, his or her nomination for election to the Board of Directors is approved or

6

recommended by a majority of the members of the Board (or of the relevant Nominating Committee) and at least five (5) members of the Board are themselves Continuing Directors at the time of such nomination; or

(iv) Any person, or group of persons, announces a tender offer for at least twenty percent (20%) of the Corporation’s Common Stock, and the Board of Directors appoints a special committee of the Board to consider the Corporation’s response to such tender offer.

     (d)(i) If any payment, accelerated vesting or other benefit provided by the Corporation to the Executive in connection with a Change in Corporate Control, whether paid or payable pursuant to the terms of this Agreement or otherwise (a “Parachute Payment”) is determined to be a parachute payment subject to the excise tax imposed by Section 4999 of the Code (such excise tax, together with any interest and penalties incurred by the Executive with respect to such excise tax, are referred to as the “Excise Tax”), the Corporation shall make an additional payment (the “Gross-Up Payment”) to the Executive in an amount such that the net amount of the Gross-Up Payment the Executive retains, after payment by the Executive of all taxes imposed upon the Gross-Up Payment, including, without limitation, the Excise Tax and any federal, state or local income taxes (and any interest and penalties imposed with respect thereto) on the Gross-Up Payment, will be equal to the Excise Tax liability imposed upon the Executive with respect to all Parachute Payments (other than the Gross-Up Payment).

     (ii) Notwithstanding the foregoing, if (1) any payments otherwise due to or on behalf of the Executive (determined without regard to paragraph 6(d)(i)) are subject to Excise Tax, and (2) a reduction in such payments otherwise subject to Excise Tax to an amount that is not less than ninety percent (90%) of the value of the payments otherwise subject to the Excise Tax would result in no Excise Tax being imposed with respect to any payments, then the payments to which the Executive is or will become entitled under this Agreement or otherwise shall be reduced to the extent required to avoid incurring the Excise Tax and no payments shall be made to the Executive under paragraph 6(d)(i).

          (e) Notwithstanding paragraph (b) above, if the Executive is a “specified employee” of the Corporation or its successor at the date of the termination of employment, the amount of the severance payment or payments which may be paid to the Executive within the first six (6) months after the date of the termination of employment shall be limited to two (2) times the lesser of (i) the Executive’s annualized compensation from the Corporation for the calendar year preceding the year of the termination, or (ii) $230,000 or such higher annual limit on the maximum annual compensation taken into account by a qualified retirement plan under Section 401(a)(17) of the Code as may be in effect for the year of the termination date. Any portion of the severance benefits which would otherwise have been paid to the Executive within the first six (6) months after the date of the Executive’s separation from service (as that term is defined under Section 409A of the Code and Treasury Regulation 1.409A-1(h) but for the delay imposed by this paragraph (e) shall instead be paid to the Executive, together with interest at an annual rate equal to the interest rate specified by KeyBank for a six-month certificate of deposit, on the first day of the first calendar month beginning at least six (6) months following the date of the termination, or, if the Executive should die before that date, be paid to the Executive’s

7

surviving spouse (or such other beneficiary as the Executive may designate in writing) as promptly as practicable after the date of death. This limitation has been inserted solely in order to comply with the requirements of Section 409A(a)(2)(B) of the Code, and shall not apply if at the date of the Executive’s termination no stock of the Corporation or its successor is publicly traded on an established securities market or if Section 409A(a)(2)(B) of the Code is not then applicable to the Executive for any other reason.

     7. DEATH

          If the Executive dies during the term of this Agreement, the Corporation shall pay to the Executive’s estate a lump sum payment equal to the sum of the Executive’s base salary accrued through the date of death, any accrued but unpaid vacation pay, plus any bonuses earned but unpaid with respect to fiscal years or other periods preceding the date of death. In addition, the Corporation shall pay to the Executive’s surviving spouse (or such other beneficiary as the Executive may designate in writing) a lump sum payment equal to the present value of a series of monthly payments for each month during the remaining term of the Agreement (but not less than twelve (12) months), each in an amount equal to one-twelfth (1/12^th) of the sum of (i) the Executive’s annual base salary, as in effect on the date of death, and (ii) the average of the annual bonuses paid to the Executive for the prior three fiscal years preceding the date of death. Such present value shall be calculated using a discount rate equal to the interest rate on 90-day Treasury bills, as reported in the Wall Street Journal (or similar publication) for the date of death. In addition, the death benefits payable by reason of the Executive’s death under any retirement, deferred compensation, life insurance or other employee benefit plan maintained by the Corporation shall be paid to the beneficiary designated by the Executive, and the stock options, restricted stock or other awards held by the Executive under the Corporation’s stock plans shall become fully vested, and, in the case of stock options, exercisable in full, in accordance with the terms of the applicable plan or plans.

     8. WITHHOLDING

          The Corporation shall, to the extent permitted by law, have the right to withhold and deduct from any payment hereunder any federal, state or local taxes of any kind required by law to be withheld with respect to any such payment.

     9. PROTECTION OF CONFIDENTIAL INFORMATION

          The Executive agrees that he will keep all confidential and proprietary information of the Corporation or relating to its business confidential, and that he will not (except with the Corporation’s prior written consent), while in the employ of the Corporation or thereafter, disclose any such confidential information to any person, firm, corporation, association or other entity, other than in furtherance of his duties hereunder, and then only to those with a “need to know.” The Executive shall not make use of any such confidential information for his own purposes or for the benefit of any person, firm, corporation, association or other entity (except the Corporation) under any circumstances during or after the term of his employment. The foregoing shall not apply to any information which is already in the public domain, or is generally disclosed by the Corporation or is otherwise in the public domain at the time of disclosure.

8

          The Executive recognizes that because his work for the Corporation may bring him into contact with confidential and proprietary information of the Corporation, the restrictions of this Section 9 are required for the reasonable protection of the Corporation and its investments and for the Corporation’s reliance on and confidence in the Executive.

     10. COVENANT NOT TO COMPETE

          The Executive hereby agrees that he will not, either during the employment term or during the period of one (1) year from the time the Executive’s employment under this Agreement ceases (for whatever reason), engage in any business activities on behalf of any enterprise which competes with the Corporation in the business of the passive ownership of senior housing or health care facilities, or passive investing in or lending to health care-related enterprises, including, without limitation, medical office buildings, hospitals of any kind, independent living facilities, assisted living facilities, skilled nursing facilities, inpatient rehabilitation facilities, ambulatory surgery centers, active adult projects or any similar types of facilities or projects. The Executive will be deemed to be engaged in such competitive business activities if he participates in such a business enterprise as an employee, officer, director, consultant, agent, partner, proprietor, or other participant; provided that the ownership of no more than two percent (2%) of the stock of a publicly traded corporation engaged in a competitive business shall not be deemed to be engaging in competitive business activities. Notwithstanding the foregoing, nothing in this section shall restrict the Executive from becoming associated with a private law firm.

          The Executive agrees that he shall not, for a period of one year from the time his employment under this Agreement ceases (for whatever reason), or, if later, during any period in which he is receiving monthly severance payments under Section 5 of this Agreement, solicit any employee or full-time consultant of the Corporation for the purposes of hiring or retaining such employee or consultant. For this purpose, the Executive shall be considered to be receiving monthly severance payments under Section 5 of this Agreement during any period for which he would have received such severance payments had such payments not been offset by compensation received from a successor employer.

     11. INJUNCTIVE RELIEF

          The Executive acknowledges and agrees that it would be difficult to fully compensate the Corporation for damages resulting from the breach or threatened breach of the covenants set forth in Sections 9 and 10 of this Agreement and accordingly agrees that the Corporation shall be entitled to temporary and injunctive relief, including temporary restraining orders, preliminary injunctions and permanent injunctions, to enforce such provisions in any action or proceeding instituted in the United States District Court for the Northern District of Ohio or in any court in the State of Ohio having subject matter jurisdiction. This provision with respect to injunctive relief shall not, however, diminish the Corporation’s right to claim and recover damages.

          It is expressly understood and agreed that although the parties consider the restrictions contained in this Agreement to be reasonable, if a court determines that the time or territory or any other restriction contained in this Agreement is an unenforceable restriction on the activities of the Executive, no such provision of this Agreement shall be rendered void but shall be

9

deemed amended to apply as to such maximum time and territory and to such extent as such court may judicially determine or indicate to be reasonable.

     12. NOTICES

          All notices or communications hereunder shall be in writing and sent certified or registered mail, return receipt requested, postage prepaid, addressed as follows (or to such other address as such party may designate in writing from time to time):

     If to the Corporation:

Health Care REIT, Inc.
One SeaGate, Suite 1500
Toledo, OH 43604
Attention: Senior Vice President-Administration and Corporate Secretary

     If to the Executive:

Daniel R. Loftus
5210 Heathrow Drive
Brentwood, TN 37027

The actual date of receipt, as shown by the receipt therefor, shall determine the time at which notice was given.

     13. SEPARABILITY

          If any provision of this Agreement shall be declared to be invalid or unenforceable, in whole or in part, such invalidity or unenforceability shall not affect the remaining provisions hereof which shall remain in full force and effect.

     14. ASSIGNMENT

          This Agreement shall be binding upon and inure to the benefit of the heirs and representatives of the Executive and the assigns and successors of the Corporation, but neither this Agreement nor any rights hereunder shall be assignable or otherwise subject to hypothecation by the Executive.

     15. ENTIRE AGREEMENT

     This Agreement represents the entire agreement of the parties and shall supersede any and all previous contracts, arrangements or understandings between the Corporation and the Executive. The Agreement may be amended at any time by mutual written agreement of the parties hereto.

10

     16. GOVERNING LAW

          This Agreement shall be construed, interpreted, and governed in accordance with the laws of the State of Ohio, other than the conflict of laws provisions of such laws.

          IN WITNESS WHEREOF, the Corporation has caused this Agreement to be duly executed, and the Executive has hereunto set his hand, as of the day and year first above written.

Attest:	HEALTH CARE REIT, INC.
/s/ Erin C. Ibele Senior Vice President-Administration	By	/s/ George L. Chapman Chief Executive Officer
and Corporate Secretary
Witness:	EXECUTIVE:
/s/ Erin C. Ibele	/s/ Daniel R. Loftus
		Daniel R. Loftus

11

EX-31.1

EXHIBIT 31.1

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

I, George L. Chapman, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of Health Care REIT, Inc.;
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 6, 2008

/s/ George L. Chapman  

George L. Chapman, 

Chief Executive Officer 

EX-31.2

EXHIBIT 31.2

CERTIFICATION OF CHIEF FINANCIAL OFFICER

I, Scott A. Estes, certify that:

1.	I have reviewed this quarterly report on Form 10-Q of Health Care REIT, Inc.;
2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
(b)	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
(c)	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
(d)	Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
(b)	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: August 6, 2008

/s/ Scott A. Estes  

Scott A. Estes, 

Chief Financial Officer 

EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350

          I, George L. Chapman, the Chief Executive Officer of Health Care REIT, Inc. (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350), that (i) the Quarterly Report on Form 10-Q for the Company for the quarter ended June 30, 2008 (the “Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and (ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ George L. Chapman George L. Chapman,

Chief Executive Officer
Date: August 6, 2008

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

EX-32.2

EXHIBIT 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350

          I, Scott A. Estes, the Chief Financial Officer of Health Care REIT, Inc. (the “Company”), certify, pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C. Section 1350), that (i) the Quarterly Report on Form 10-Q for the Company for the quarter ended June 30, 2008 (the “Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and (ii) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Scott A. Estes Scott A. Estes,

Chief Financial Officer
Date: August 6, 2008

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.